Miniaturizing Medicine – Strategies for Developing and Improving Point-Of-Care Biosensors by Ogden, Nathan Elliot
UC Santa Barbara
UC Santa Barbara Electronic Theses and Dissertations
Title
Miniaturizing Medicine – Strategies for Developing and Improving Point-Of-Care Biosensors
Permalink
https://escholarship.org/uc/item/6vh6c830
Author
Ogden, Nathan Elliot
Publication Date
2019
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
UNIVERSITY OF CALIFORNIA 
Santa Barbara 
 
 
Miniaturizing Medicine – Strategies for Developing and Improving  
Point-Of-Care Biosensors 
 
 
A dissertation submitted in partial satisfaction of the 
requirements for the degree Doctor of Philosophy 
in Materials 
 
by 
 
Nathan E. Ogden 
 
Committee in charge: 
Professor Kevin Plaxco, Co-Chair 
Professor Craig Hawker, Co-Chair 
Professor Omar Saleh 
Professor Cyrus Safinya 
 
December 2019 
  ii 
 
 
 
The dissertation of Nathan E. Ogden is approved. 
 
  ____________________________________________  
 Omar Saleh 
 
  ____________________________________________  
 Cyrus Safinya 
 
 _____________________________________________ 
 Craig Hawker, Co-Chair 
 
  ____________________________________________  
 Kevin Plaxco, Co-Chair  
 
 
 
 
 
 
 
December 2019  
  iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Miniaturizing Medicine – Strategies for Developing and Improving  
Point-Of-Care Biosensors 
 
Copyright © 2019 
by 
Nathan E. Ogden
  iv 
ACKNOWLEDGEMENTS 
 
I should begin by thanking my wonderful wife, Pritha. Besides being a lovely person, she 
has supported and enabled my otherwise crippling educational habit for these past six years 
and I am eternally grateful to her for that. I swear that I am going cold turkey after this. I 
would also like to thank my parents for their role in getting me hooked on education in the 
first place. If you think about it, this whole thing really is your fault. Last amongst my 
enablers, I would also like to thank Prof. Kevin Plaxco for taking me in when I was a cast-
off graduate student. Thank you for taking a chance on me. I hope something good came of 
it. 
 
There are also quite a few people who I would like to thank for their individual 
contributions. I would be remis if I did not mention Peter Mage for teaching me all about the 
fine art of microfluidics, which forms the foundation of the second chapter of this thesis. On 
that same project, I would also like to mention Dan Mamerow’s contributions in testing 
various reagents and helping to run the experiments. Additionally, I would also like to thank 
Dr. Andrew Csordas for his role in teaching me about aptamers and for helping me develop 
(yet another) thrombin aptamer.  
 
I would also like to thank everyone from the Plaxco lab for being a wonderfully entertaining 
and welcoming group of people to work with. I could not ask for better lab mates than y’all. 
There are a few people who deserve special mention here, however. Dr. Claudio Parolo was 
an early mentor for me and taught me all about how to make scaffold sensors. The third 
  v 
chapter of this thesis would not have been possible if not for him. I’d also like to thank Dr. 
Martin Kurnik who, besides providing hours of conversation about science and obscure 70’s 
and 80’s musicians, was instrumental in teaching me everything I know about protein 
synthesis. If I ever need syphilis proteins ever again, you will be my first call. I’d also like to 
thank Dr. Alejandro Chamorro and Dr. (very soon to be Professor) Philippe Dauphin-
Ducharme for allowing me to use their data to compare against my simulations. Lastly, I 
would like to thank Dr. Kyle Ploense for his assistance in performing in-vivo experiments. 
That material didn’t make it into this thesis, unfortunately, but I appreciate it all the same.  
To anyone who’s contributions I failed to mention, I am sorry. The fault lies not with you 
but rather with my terrible memory. To quote Bilbo Baggins “I don’t know half of you half 
as well as I should like; and I like less than half of you half as well as you deserve.” 
  vi 
VITA OF NATHAN E. OGDEN 
November 2019 
 
EDUCATION 
UC Santa Barbara, Department of Materials Science 
Doctor of Philosophy in Materials Science 
 
 
Santa Barbara, CA 
Rice University, Department of Physics and Astronomy 
Bachelor of Science in Applied Physics 
Houston, TX 
May 2013 
 
 
PUBLICATIONS 
 
Ogden, N., Dauphin-Ducharme, P., Chamorro, A., Plaxco, K. (2019) “Towards the rational 
optimization of aptamers for electrochemical sensors” (In preparation) 
 
Ogden, N., Kurnik, M., and Plaxco, K. (2019) “An electrochemical scaffold sensor for rapid 
syphilis diagnosis” Analyst 144.17 
 
Parolo, C., Greenwood, A., Ogden, N., Kang, D., Hawes, C., Arroyo-Curras, N., and 
Plaxco, K. (2019) "E-DNA scaffold sensors for the multiplexed detection of HIV-diagnostic 
antibodies in authentic patient samples" Analytical Chemistry (Submitted) 
 
Arroyo-Curras, N., Sadeia, M., Ng, A., Fyodorova, Y., Williams, N., Afif, T., Ogden, N., 
Andresen, R., Plaxco, K., and Lukeman, P.  (2019) “An Electrochemical Biosensor 
Exploiting Conformational Changes in Electrode-Attached DNA Origami to Detect Hundred 
Nanometer-Scale Targets” Angevandte Chemie, (Submitted) 
 
Kang, D., Parolo, C., Sun, S., Ogden, N., Dahlquist, F., and Plaxco, K. (2018) “Expanding 
the Scope of Protein-Detecting Electrochemical DNA “Scaffold” Sensors” ACS Sensors 3.7  
 
Haugan, H., Brown, G., Mahalingam, K., Grazulis, L., Now, G., Ogden, N., and Kono, J. 
(2014) “Optimum growth window for InAs/GaInSb superlattice materials tailored for very 
long wavelength infrared detection” Journal of Vacuum Science and Technology B 32.2 
 
Haugan, H., Brown, G., Elhamri, S., Mitchel W., Mahalingam K., Kim M., Noe G., Ogden, 
N., and Kono, J. (2012) "Impact of Growth Temperature on InAs/GaInSb Strained Layer 
Superlattices for Very Long Wavelength Infrared Detection." Applied Physics Letters 
101.17 
 
  vii 
Slaughter, L., Willingham, B., Chang, W., Chester, M., Ogden, N., and Link, S. (2012) 
"Toward Plasmonic Polymers." Nano Letters 12.8 
 
  viii 
ABSTRACT 
 
Miniaturizing Medicine – Strategies for Developing Point-Of-Care Biosensors 
by 
Nathan E. Ogden 
 
Each moment of each day countless millions of proteins circulate through the body, 
performing their tasks, recognizing and binding to their targets, all with minimal crosstalk 
between the countless other proteins circulating alongside them. It is no wonder then, that, 
when faced with problems such as detecting rare molecular targets within complex 
backgrounds, technology developers often employ biological molecules as the foundation 
with which to build sensors (“biosensors”) and develop processes (“bioassays”). But that is 
not to say that sensors and assays based on biorecognition are perfect. Bioassays, for 
example, are generally complex, time-consuming processes and thus they provide actionable 
information only after a significant time lag. Biosensors (such as blood glucose meters), in 
contrast, can provide real-time information, but those few that work in realistically complex 
sample matrices invariably rely on the specific chemical reactivity of their targets, greatly 
limiting the range of molecules they can detect. Motivated by these concerns, I have been 
exploring biosensors and bioassays that, unlike existing approaches, are simultaneously 
general and capable of rapidly returning answers.  
 
The first strategy I have explored utilizes microfluidics to adapt existing, multi-step 
bioassays into a rapid-and-convenient point-of-care device. Specifically, taking advantage of 
the inherent automation potential of microfluidics I have shown it possible to automate and 
speed up an established, bench-top bioassay. Once fully automated, the assay can even be 
  ix 
used to perform continuous measurements, tracking changes in the concentration of a target 
protein in a clinical sample stream in real-time. 
 
The second strategy that I explored was the development of a single-step, reagentless 
biosensor platform termed electrochemical DNA-based (E-DNA) sensors. This broad class 
of electrochemical sensors utilizes binding-induced changes in the structure or dynamics of 
an electrode-bound biomolecule to reagenltessly and continuously report on the 
concentration of its target. Specifically, this class of sensors uses DNA either as a scaffold 
upon which to display a recognition element (scaffold-sensors), such as an antigen, or as the 
recognition element itself (aptamer-based sensors). Using Monte-Carlo simulations I have 
examined how changing the molecular weight of a recognition element affects the 
performance of scaffold sensors and used this information to develop a point-of-care 
serological assay to help rapidly diagnose syphilis. Using a similar Monte-Carlo model I 
likewise optimized the performance of aptamer-based sensors by examining how 
modifications around the aptamer’s binding pocket affect sensor performance. Together 
these studies are helping to bridge the gap between complex (but generalizable) bioassays 
and simple to use biosensors (such as blood glucose meters) which cannot readily be 
adapted to other targets. 
  x 
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“All this science I don’t understand, 
It’s just my job five days a week” 
-Elton John  
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I. Introduction 
 
Motivation 
Biological recognition is incredibly powerful. Consider, for instance, the cytokine TNFα, an 
important signaling protein which is in part responsible for inducing cell death and initiating 
the body’s inflammation response. While prompting cell death is at times essential for life, if 
TNFα was to bind to targets other than its intended ones, it would be disastrous. And yet 
TNFα performs its task day after day, year after year, in organisms all across the globe. And 
this is just one protein working amongst many thousands of others, each preforming its own 
task, binding to its own target with minimal cross-talk between them. It is no wonder then, 
that, when faced with problems such as detecting rare molecular targets within complex 
backgrounds, technology developers often employ biological molecules as the foundation 
with which to build sensors (“biosensors”) and develop processes (“bioassays”). Whether it 
be measuring glucose in diabetic patients, measuring disease markers in plasma, or 
measuring the concentration of contaminants in food or beverages or soil or water, 
biological recognition plays an essential role in how we measure molecules in the modern 
world. That is not to say that sensors and assays based on biorecognition are perfect. Indeed, 
there remains much room for improvement and, as a result, it is these sorts of biosensors and 
bioassays which we will interest ourselves in this thesis. 
 
Before discussing how to improve biosensors and bioassays (hereafter we will refer to the 
two interchangeably), it is worth asking what attributes comprise the ideal biosensor? 
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Arguably the most important is that a biosensor must have a low enough limit of detection to 
measure its target. In fact, a sensor which fails in this criterion really is no sensor at all. That 
is not to say, however, that the ability to measure small concentrations of target is the end all 
and be all of the ideal biosensor. It is easy to imagine cases where a sensor might be too 
sensitive to perform a useful function. Consider the example of a biosensor which works 
through the binding of a signaling protein to a target. The protein has some affinity towards 
its target, frequently given in terms of the dissociation constant, Kd. If we are in a situation 
where the amount of target is far in excess of the amount of the amount of affinity reagent 
(as is often the case in sensors where a limited amount of affinity reagent is conjugated to a 
surface), then we can think of the Kd as being the concentration of target at which half of our 
affinity reagents are bound. Clearly it is desirable that our hypothetical protein has a high 
affinity for its target (i.e., a low Kd), but only insofar as it relates to the expected amount of 
target present in our analyte. Too low of a Kd and we would completely saturate our sensor 
even at modest target concentrations, leaving it just as useless as a sensor with too high of a 
Kd, that does not appreciably bind its target.  As a result, while many papers seek ways to 
push the limit of detection of their sensors, it is always worth keeping in mind that we 
should aim for a sensor which can perform measurements over a relevant dynamic range for 
a given target rather than necessarily pursuing sensitivity for its own sake. 
 
If a properly matched dynamic range is the primary criteria for building a sensor, then 
selectivity is the second criteria that we should be concerned with. Consider, for instance, a 
non-biological based technique such as mass spectrometry. This is powerful analytic 
technique which allows researchers to measure picograms of material and can be used to 
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verify the purity of a sample and detect trace amounts of contaminants1,2. This ability to 
measure very low concentrations of target comes at a cost, however. Due to the sheer 
number of background molecules with overlapping signal, mass spectrometry is limited to 
measuring relatively pure samples. As a result, it must be paired with dilution, filtration, and 
generally some sort of purification, such as that achieved via gas chromatography, liquid 
chromatography, or capillary electrophoresis3–5. This makes it a fine research tool and an 
excellent quality control assay but leaves it poorly suited to clinical diagnostics where the 
expense and complication of purifying the sample oftentimes outweighs the benefits gained 
by high sensitivity. It is for this reason that biosensors are so attractive, since biological 
affinity reagents have already evolved to work in situ in the body, among the most complex 
of backgrounds. There are many ways to make far simpler sensors with a degree of 
specificity by introducing affinity reagents such as antibodies which attempt to sequester the 
target of interest. One example of such a sensor would be a micromechanical sensor in 
which an affinity reagent such as an antibody is immobilized on the surface of a cantilever6–
8. Binding between the antibody and its target is then accompanied by a change in the weight 
of the cantilever. This, in turn, causes a change in the resonant frequency of the cantilever, 
which may be measured in order to quantify the amount of the target bound to the surface 
[Figure 1a]. A similar analogue with an electric readout would be a biologic field effect 
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transistor (bio-FET). Here affinity reagents are placed in the gate region of a field effect 
transistor and the binding of the target of interest modulates the resistance between the 
source and the drain [Figure 1b]9–11. A fatal drawback with these sorts of sensors which rely 
entirely on adsorption to drive signal change is that while the presence of an affinity reagent 
enhances the likelihood of the target binding to the surface, it does not prevent non-specific 
binding. Since there is no way to discern the difference between off-target signal due to non-
specific binding of biomolecules to the cantilever/transistor and signal due to the target, 
these sensors fail when challenged with realistically complex samples. This leaves them 
Figure 1 An illustration of two biosensing strategies relying on affinity reagents to sequester target. a) 
Microbalance sensors measure the resonant frequency of a lever which has been functionalized with an antibody 
(or other affinity reagent). The binding of target to the sensor changes the mass on the lever, which in turn 
changes the resonant frequency. b) A typical bio-FET sensor scheme in which a conductive source and drain 
are separated by a semiconductor which has been modified with an affinity reagent. Binding of the target 
modulates the resistance of the semiconductor, changing the amount of current which flows from the source to 
the drain. 
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unsuitable for deployment in complex media such as blood or serum since the sheer number 
of non-target proteins means that false signal due to unpredictable nonspecific binding 
events will outweigh the signal due to specific binding to the affinity reagent.    
 
One method to avoid the problems described above is to co-opt proteins which can be 
adapted to generate a signal on their own rather than merely binding to its target. One of the 
most recognizable of such sensors is the blood glucose meter. First developed in 1962 
[ref12], early glucose measuring devices used a colorimetric readout, but more modern blood 
glucose meters utilize an electrochemical readout which is simpler to use and provides a 
quantitative readout13. While there have been many advancements towards improving the 
reliability and accuracy of electrochemical blood glucose meters, they all have a similar 
method of operation14–17. Generally, a thin coating of glucose oxidase is applied to an 
electrode surface. The electrode is exposed to the analyte (typically blood drawn through a 
fingerpick) at which point the enzyme on the electrode surface reacts with glucose. Glucose 
oxidase is then re-oxidized by a mediator molecule, which generates a current which can be 
measured using a hand-held device. This current is proportional to the amount of enzyme 
being oxidized, which is in return proportional to the amount of glucose present in the blood. 
Since glucose oxidase is an enzyme which has already evolved to work in complex media, it 
is highly specific towards its target and there is negligible signal contribution from off target 
binding, despite the complexity of the analyte. The result is a biosensor highly specific to 
glucose which is small enough to fit in the palm of a patient’s hand, rapid enough that a 
patient can immediately take corrective measures if the sensor indicates an adverse result, 
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and cheap enough that almost every diabetic patient in the United States owns one. In short, 
glucose monitors are everything that could be reasonably asked for in a biosensor.  
 
If the blood glucose meter represents the ideal molecular sensor to which we strive, why 
then have we not seen similar biosensors for targets other than glucose? The answer lies 
within the enzyme that provides the signal transduction at the heart of the glucose sensor. 
We are extremely fortunate that glucose oxidase evolved the way that it did. If it were not 
for the convenient fact that glucose oxidase reacts with glucose in a fashion which can be 
detected electrochemically, then glucose monitors such as we know them would not work. 
Unfortunately, the list of enzymes which bind to a diagnostically relevant target and can be 
used to generate an electrochemically active product is incredibly short. Outside of a few 
niche cases, we are therefore limited to designing sensors around affinity reagents which 
bind to their targets but do not generate an electroactive product. The trick is then to find a 
way to link these binding events with a readout capable of discerning between bound and 
unbound reagents which does produce significant signal due to non-specific binding. 
 
Given the challenge of creating a single-step sensor that can discern between specific and 
non-specific binding, it is far more common to develop complex and time-intensive 
procedures to perform the desired task. One of the most common assays of this sort is the 
enzyme linked immunosorbent assay (ELISA)18. As the name implies, ELISAs rely on 
naturally produced antibodies as their recognition element19. While there are many variants 
of ELISA assays, a representative scheme is shown in Figure 2. A technician will generally 
start by pipetting analyte into the wells of a 96 well plate which have been pre-coated with a 
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“capture” antibody. Depending on the concentration of target in the sample, some of it will 
bind to the capture antibody. After letting the sample incubate in the well for a pre-
determined amount of time, the plate is washed and then a second “recognition” antibody is 
introduced. This antibody binds to whatever target has been immobilized by the capture 
antibody, forming a “sandwich.” In some cases, the recognition antibody is labeled with an 
enzyme while in other cases a third, labeled, antibody is introduced which binds to the 
recognition antibody. In either case, the plate is washed again, and a fluorescent substrate is 
introduced which is catalyzed by the enzyme linked to one of the antibodies. This creates a 
colorimetric signal which can either be interpreted by eye or with the aid of a fluorescent 
plate reader. Since the immune system is naturally capable of generating antibodies against 
foreign bodies, it is possible to create antibodies against a wide variety of targets. The result 
is a sensitive and specific assay which is inherently much more generalizable than enzyme-
based assays which only work in niche cases. Unfortunately, this comes at a cost. ELISAs 
are not easy to perform – they require a trained technician to carry out the steps of the assay. 
They are not quick – it can take hours of incubation time and multiple wash steps before 
reaching a result. Lastly, they are not portable – they require several sets of reagents (which 
often must be kept refrigerated) and the plate readers required to interpret the results are 
large and bulky. The combination of these drawbacks means that ELISAs and similar 
immunoassays are not performed at the point of care, but instead typically performed in 
specialize off-site labs. This introduces considerable delay between when a patient initially 
visits their doctor or caregiver and when they receive the results of the assay. 
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While the above should hardly be thought of as an exhaustive review of current biosensing 
strategies, it does illustrate the chief dynamic which hinders further progress in the field. 
There are a few commercially available point-of-care sensors, such as blood glucose meters 
or pulse oximeters, which fulfill all of the desired requirements for a biosensor, but they rely 
on specific chemistries or biomolecules which cannot be adapted to other targets. For the 
vast quantity of remaining targets, we are forced to rely on cumbersome assays which 
require a trained user to perform and can take hours to reach a result. While given enough 
time and resources we are currently capable of measuring almost any target in almost any 
analyte, there are many scenarios where both time and resources are scarce. The focus of 
this thesis will therefore be bridging the gap between generalizable but resource-intensive 
assays and niche-use but cheap, fast, and portable biosensors. We will show two approaches 
to solve this problem. This first, detailed in Chapter II, will be using microfluidics to adapt 
well-proven clinical assays to a point-of-care device. The second approach will be to 
Figure 2 (a) In a typical ELISA, the wells of a microplate are coated with an antibody against the target of 
interest. (b) The analyte is then introduced into the well where it is allowed to incubate. The antigen eventually 
diffuses to the surface and binds to the antibodies coating the well. (c) The user then washes the plate and 
introduces a secondary antibody which forms a sandwich around the antigen. Typically this secondary antibody 
is either linked to an enzyme or a further enzyme linked antibody is introduced targeted towards the secondary 
antibody. (d) The plate is then washed again and a substrate is added which is converted by the enzyme to a 
fluorescent product. After allowing the sample to incubate for a set period of time, the reaction is halted and the 
fluorescence measured.  
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improve upon innovative electronic DNA based sensors, for which further background is 
given below. 
 
Electrochemical DNA Based Sensors 
In an attempt to combine the beneficial qualities of blood glucose meters, such as ease of 
use, rapid time to response, and small form factor, into a sensor that could be adapted to 
many different targets ranging from small molecules to proteins, of the Plaxco group began 
developing Electrochemical DNA sensors (E-DNA sensors). The first sensor in this class, 
published in 2003, was designed to recognize short segments of single stranded DNA or 
RNA20 and was followed by several variants intended to improve on the original design21–24. 
The general method of operation for all of these sensors is that specific binding between the 
sensor and the target of interest changes the rate at which a redox reporter is capable of 
approaching the surface. For the early E-DNA sensors, a sequence that is complementary to 
the target sequence is modified on the 3’ end with a thiol group and on the 5’ end with a 
methylene blue molecule which serves as a redox reporter [Figure 3]. The complementary 
sequence is then bound to the surface of a gold electrode using a gold-thiol bond and the 
sensor surface is backfilled with a protective monolayer. The completed sensor can then be 
immersed in a solution containing the target strand. In the absence of the target sequence, 
the tethered DNA is flexible, and the redox reporter is able to freely approach the surface. 
When the electrode is interrogated with a technique such as square wave voltammetry, the 
redox reporter produces a measurable Faradic current. In the presence of the target sequence, 
however, the target and its complement form a double stranded sequence which is far more 
ridged than the single stranded DNA alone. This has the effect of reducing the frequency 
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with which the redox reporter is able to approach the surface, therefore reducing the 
measured Faradic current measured in a manner proportional to the concentration of the 
target DNA sequence. Because the signal change is driven by the conformational change 
arising from the binding of the recognition strand to its complement (as opposed to the 
binding of a molecule to the surface), the technique is highly specific as demonstrated by its 
use in blood serum, saliva, and cellular extract22.  
 
Electrochemical Aptamer-Based Sensors 
While the original E-DNA sensors could be modified to recognize effectively any nucleic 
acid sequence, single stranded oligonucleotides represent only a tiny fraction of the space of 
interesting biosensing targets. A major set forward for E-DNA sensors was therefore the 
development of electrochemical aptamer-based (E-AB) sensors. Aptamers are short 
oligonucleotide sequences which bind selectively to a target and were discovered 
independently by two different groups in 1990 [ref25,26]. While we typically think of nucleic 
Figure 3 While there are many variants, in the simplest example of an E-DNA sensor, a methylene blue 
redox reporter modified DNA sequence is attached to an electrode surface. Due to the flexibility of single 
stranded DNA, the redox reporter is able to move relatively freely in the unbound state, leading to a high 
electron transfer rate between the reporter and the surface. When the complementary DNA strand binds to the 
reporter strand, it forms a double stranded DNA complex which is far more ridged, leading to a lower electron 
transfer rate. 
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acids as storing or transmitting genetic information, aptamers are functional molecules and 
are not found in naturally. Instead, they are purposefully developed in a laboratory setting, 
typically through some variation of a process known as systematic evolution of ligands by 
exponential enrichment (SELEX). In this process, a large library of randomly generated 
nucleotide sequences, typically containing on the order of 1015 sequences, is exposed to a 
target of interest, generally immobilized on some sort of solid support. While the vast 
majority of sequences will not bind to the target, a small fraction will. These sequences can 
be isolated, usually through the means of sequential washing steps, and then enriched 
through polymerase chain reaction. The result is a subset of the library of sequences that is 
biased towards sequences that bind the target. Through repeating this process several times, 
it is possible to narrow the initial library of trillions of sequences down to the handful of 
sequences capable of binding the target. These can then be individually characterized in 
order to find the best sequence, whether that be the one with the lowest Kd, the most 
selective sequence, or some combination thereof. Since aptamers are short, single stranded, 
oligonucleotide sequences which selectively bind to a target it is fairly straightforward to 
adapt them to the E-DNA platform, as first demonstrated by Xiao et al. in 2005 [ref27]. 
Subsequent publications have shown that this method is quite generalizable, with examples 
of E-AB sensors being used to detect targets ranging from small molecule drugs to 
proteins28–31. As with previous E-DNA sensors, E-AB sensors are resistant to spurious 
signals due to off-target binding because the signal change is driven by conformational 
changes of the aptamer upon binding to its target rather than the simple process of a 
molecule binding to the surface itself. Thus, not only have E-AB sensors been used in 
complex media, but recently they have been adapted for use in implantable sensors used to 
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take measurements in vivo32,33. Still, while adapting aptamers for use in E-AB sensors 
initially sounds trivial, this is not always the case. Often researchers find that aptamers 
which have been demonstrated to work well in solution perform poorly when attached to the 
surface of an electrode. In these cases, it becomes necessary for the researcher to make 
modifications to the aptamer sequence, a process which can devolve into a trial and error 
affair. Efforts to improve this process are described in Chapter IV.  
 
DNA Scaffold Sensors 
The last class of sensors which we will discuss in this thesis are DNA scaffold sensors. 
While there have been many efforts to identify aptamers for clinically useful targets, the 
field suffers from two key problems. First, since aptamers were only first described in the 
1990’s and remained a niche topic for some time after, there has been relatively little time to 
develop aptamers compared to the amount of time and effort which has been expended 
towards identifying and characterizing other biomolecules, whether that be the development 
of antibodies for various targets, or the identification of binding epitopes for those 
antibodies. The second problem facing the aptamer field is that DNA (and RNA) present a 
limited chemical library from which to create an affinity reagent as compared to proteins. 
While there have been some attempts to rectify this through the use of non-natural bases34–37 
the end result is that aptamers for some targets remain stubbornly elusive. Either it is 
impossible to find aptamers against them, or the aptamers are of such poor affinity that they 
are not practically useful for creating sensors. To circumvent this issue, the Plaxco group 
developed a new class of sensors known as scaffold sensors38–40. Instead of relying on 
aptamers as the recognition element, scaffold sensors are capable of displaying peptides or 
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small proteins as the recognition element, vastly expanding the space of measurable targets. 
As with the rest of the E-DNA sensors, scaffold sensors start as a single stranded, methylene 
blue modified, DNA sequence bound to the surface of a gold electrode. For scaffold sensors, 
however, this initial “anchor” strand is then bound to a complementary peptide nucleic acid 
sequence which then displays a short peptide epitope. Binding of a target to the epitope 
changes the rate of electron transfer between the methylene blue and the surface, generating 
a measurable signal change [Figure 4]. A further examination of the physics of these sensors 
as well as a demonstration of their practical utility as a diagnostic device is demonstrated in 
Chapter III.  
 
Figure 4 The recognition element of a scaffold sensor consists of a methylene blue modified anchor 
strand bound to the surface of an electrode. A complementary strand bearing either a short peptide or a small 
protein is conjugated to a complementary strand which then binds to the anchor.  Binding of the target protein 
to the peptide reduces the efficiency with which the redox reporter is able to approach the surface, thus 
lowering the electron transfer rate of the sensor 
  14 
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II. Continuous, real-time microfluidic immunoassay 
Introduction 
In this chapter we discuss the development of a novel device designed to circumvent the 
shortcomings of traditional bioassays by taking advantage of the inherent automation 
potential of microfluidics. Given the massive dynamic range of the human proteome, a great 
deal of effort has been placed into increasing the sensitivity of modern affinity reagent based 
biosensors 1–3. Lowering the limit of detection allows researchers to gain insight into the 
concentration of low abundance proteins, and aids in the search for biomarkers which can 
signal disease 4. The common drawback of these sensors, however, is that they are purely 
end-point measurements. They rely on techniques that take trained users several hours to 
carry out and, as a result, they offer little insight into how protein concentrations may 
change as a function of time. Nevertheless, there are many serious conditions which could 
be detected, and therefore treated, more effectively if, rather than focusing purely on 
lowering the limit of detection, we could instead measure changes in a reporter protein's 
concentration in real-time. Disseminated intravascular coagulation (DIC), for instance, is a 
condition whose effects are characterized by widespread activation of the coagulation 
pathway, leading to clot formation, followed by organ failure, and eventually death5. 
Typically, this happens in patients already compromised by some other serious condition 
and, as a result, leads to a high mortality rate. Nevertheless, there is not currently any single 
laboratory test designed to diagnose DIC. Doctors are instead forced to form a diagnosis 
based off a scoring system which assigns point values to various physical symptoms6.  By 
continuously measuring the concentration of one (or several) of the proteins involved in the 
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coagulation cascade, care-givers would be able to administer treatment earlier and, thus, 
lower the risk of fatal complications.  
 
Recent years have seen some success in measuring protein concentration as a function of 
time in buffer and dilute serum using electrochemical7,8 and optical9 means. Unfortunately, 
nonspecific adsorption of proteins and cells from whole blood onto sensor surfaces leads to 
rapid signal degradation in many of these approaches10. Meanwhile, the poor optical 
qualities of whole blood and blood serum likewise renders fluorescent detection 
problematic11,12. As a result, many otherwise promising strategies for continuous protein 
monitoring are ill suited for clinical use. By combining the processing steps, washing steps, 
and measurement steps of a traditional immunoassay onto a single device capable of 
continuous readout, we can track the change of concentration of a sample protein in whole 
blood in real-time while avoiding many of the pitfalls which limit current techniques.  
 
The most interesting proteins to measure in real-time would be those involved in the 
coagulation cascade since their concentration can change several orders of magnitude in a 
short span of time and the resulting changes have obvious clinical importance. As an initial 
proof of concept however, we have used our device to measure in vitro concentrations of the 
cytokine protein tumor necrosis factor alpha (TNFα). We chose TNFα as a preliminary 
target for two reasons: first, there exists a set of affinity reagents capable of forming a 
sandwich complex, one reagent being a monoclonal antibody and the other being a recently 
discovered DNA aptamer selected for its specificity in serum13. Second, while TNFα is 
naturally present in the blood stream, it typically exists at sub-picomolar concentrations14,15, 
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allowing us to dope unmodified whole blood with nanomolar to micromolar concentrations 
of protein without having to worry about signifigant background signal arising from the 
protein naturally present.  
  23 
Theoretical Background 
Motivating Microfluidics 
In order to adapt an existing benchtop assay to a point-of-care device, we will leverage 
microfluidics to fully automate all of the sample processing steps. This removes the need for 
trained technicians to operate the assay as well as removing the need for specialized lab 
space to analyze patient samples. The combined effect is that we can shift care from 
centralized lab facilities to the point of care itself, resulting in minimal lag time between 
when a care giver takes a sample and when the results of whatever assay being run is 
returned. It is worthwhile, therefore, to spend some time discussing the theoretical 
background of microfluidics in greater detail. What, for example, defines microfluidics as 
opposed to “macro”-fluidics? Besides the obvious advantage of handling small samples 
sizes, what advantages does microfluidics confer over a larger system? And finally, how can 
we adapt the steps of a traditional benchtop assay, such as the mixing and separating 
reagents, to a fully automated system? 
 
Defining Microfluidics 
The simplest definition of “microfluidics” would be any fluidic device which holds 
microliter volumes of reagents. This definition, however, does little to communicate the 
physical properties which set microfluidics apart from any other regime of fluid mechanics. 
In order to understand the physics of microfluidics, we can first start with the Navier-Stokes 
equation, which arises from Newton’s second law of motion as applied to fluids and 
describes the velocity field of a Newtonian fluid as it is acted upon by a set of forces such as 
shear forces and pressure differentials: 
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𝜌
𝜕?⃑? 
𝜕𝑡
=  ∇𝜎 + f = − ∇p + η∇2u⃑ + f  
Here 𝜌 is the density of the fluid, 𝑢 is the velocity  𝜎  represents the force per unit area 
exerted by surfaces, f represents body forces (i.e. forces which are exerted on the entirety of 
the fluid), and η is the shear viscosity. While the Navier-Stokes equation is capable of fully 
describing any arbitrary fluid system, it lacks an analytic solution outside of a few 
specialized cases. As a result, while highly useful for numerical simulations, it provides little 
intuition into the behavior of a system. If we wish to gain an understanding of the behavior 
of some arbitrary system without resorting to highly detailed numerical modeling (we do), 
then it becomes useful to instead define dimensionless parameters which can capture a 
snapshot of the behavior of a system without requiring extensive calculations. 
 
The parameter most associated with microfluidics is the Reynolds number16–18. This 
dimensionless parameter describes the ratio between the inertial and viscous forces on a 
fluid: 
𝑅𝑒 =  
𝜌𝑈𝑜𝐿𝑜
𝜂
 
where 𝑈𝑜 is an average characteristic velocity of the system, 𝐿𝑜 is a characteristic length, 
and as above 𝜌 is the density of the fluid and η is the shear viscosity. In our typical day-to-
day experience, we are accustomed to fluidic systems dominated by inertial effects (𝑅𝑒 >
1). Examples of such systems would be water flowing through large diameter pipes, rivers, 
streams, or virtually any other fluid system which we interact with on a day-to-day basis. In 
such systems, we expect that inertia will cause a fluid in motion will stay in motion while 
turbulence will randomly mix and disrupt the flow in a chaotic fashion. Microfluidics, 
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conversely, can be thought of as the regime where this no longer holds true. If the 
characteristic length scale is small enough relative to the fluid viscosity to where the 
Reynolds number is much less than 1, then the behavior of the system changes completely19. 
In this regime, the behavior of the system is entirely dominated by forces currently acting on 
the system – either viscous forces or pressure differentials actively pumping liquid through 
the channel. Instead of the turbulent mixing flow which we are accustomed to, here instead 
we see completely laminar flow. As a result, flow through the system is (almost) completely 
reversible. The only mixing which takes place is through diffusion, a process which 
typically takes orders of magnitude longer than turbulent mixing.  
 
Advantages of Microfluidics 
Now that we have defined what constitutes the microfluidic regime, the next question is why 
we should care. What advantages does being in a system dominated by viscous forces 
confer? The answer to this question is control. Because we do not have to worry about 
turbulent mixing, it is possible to exert a great deal of control over our system. For example, 
rather than attempting to solve the Navier-Stokes equation for a system, it is possible to 
reduce the problem to something analogous to Kirchhoff's circuit laws for electronics20. We 
can convert the traditional circuit equation  
Δ𝑉 = 𝐼𝑅 
where Δ𝑉 is the voltage differential across a circuit, 𝐼 is the current and 𝑅 is the resistance, 
to an analogous “microfluidic circuit” equation:  
Δ𝑃 = 𝑄𝑅ℎ 
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where Δ𝑃 is the pressure differential, 𝑄 is the flow rate, and 𝑅ℎ is the hydrodynamic 
resistance, which can be calculated based off the channel geometry as well as the fluid 
viscosity. Using this technique, it is possible to create microfluidic “circuits” with complex 
junctions where, instead of attempting to numerically solve the Navier-Stokes equation, the 
user can instead calculate approximate behavior. As one example, microfluidics have been 
used to create highly reproducible droplet generators21–24. These devices typically take the 
form of a four-way junction where one inlet contains a reagent and two perpendicular inlets 
contain a non-miscible liquid such as mineral oil. At the junction, droplets are created as the 
reagent stream is encapsulated by the oil streams. Each droplet can be used as a mini-
reaction chamber where the amount of reagents introduced as well as the amount of time the 
reaction is allowed to take place can be passively controlled by the design of the mixer 
itself25. Because there is no turbulence and all of the flow parameters satisfy Kirchhoff’s 
laws, the entire process is inherently automated and reproducible.  
 
It is also possible to take advantage of Kirchhoff’s laws in order to sort particles inside of 
microfluidic chambers. If we create a microfluidic junction where two smaller channels split 
off of a main channel, it is easy to calculate the flow rate through each of the smaller 
channels and, since flow through microfluidic systems is laminar, it is trivial to predict 
which outlet a particle traveling in the main channel will exit towards. Particle sorters such 
as this have been shown to work in microfluidic chambers via magnetophoresis, 
acoustophoresis, electrophoresis, or other techniques26–28. For more complex devices, it is 
also possible to create microfluidic valves to further control flow and to isolate reagents 
from one another until some pre-determined time29. 
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Adapting Benchtop Assays 
As discussed above, microfluidics is a powerful tool for controlling the behavior of fluids 
(and particles suspended in those fluids). It is not too difficult to imagine how it would be 
possible to take advantage of this fact to adapt a benchtop assay to a single “lab-on-a-chip” 
device. If we consider the example of a user wishing to perform an immunoassay on some 
sort of solid support, the user would likely perform the following steps: 
 
1. Mix the solid support (with some sort of capture reagent conjugated to the 
surface) with the sample 
2. Wash 
3. Mix in a labeled reagent 
4. Wash 
5. Measure the resulting signal 
 
Since microfluidics gives us a great deal of control over the behavior of our system and we 
do not have to worry about turbulent mixing, it is easy to imagine a device which breaks this 
process down into a few discrete chambers, each performing their allotted task in sequence. 
The only major issue we can expect is with the mixing steps. Almost any assay will require 
some set of reagents to be mixed together at some point during the process. As previously 
discussed, however, the very thing that characterizes microfluidics is that there is no 
turbulent mixing inside of a microfluidic channel. In order to automate an assay, it is 
therefore necessary to somehow disrupt the laminar flow. Luckily, this problem has already 
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been solved by the Whitesides group amongst others30,31. By introducing a series of raised 
herringbone patterns decorating one side of a microfluidic channel, they were able to locally 
disrupt laminar flow through the chamber, allowing them to mix two inlets much more 
efficiently than by relying on diffusion alone. This gives us the last component necessary to 
automate an assay. We can now easily imagine a device where reagents on a solid support 
are introduced, mixed with the sample, allowed to incubate, and then sorted out of the 
sample into a washing buffer where they can be analyzed. 
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Results 
Device Design 
Our goal is to take full advantage of microfluidics in order to create a chip which can 
passively automate a complex assay. In this specific case, we have designed a device which 
utilizes magnetic microbeads as a solid support for performing an on-chip fluorescence-
based sandwich assay. The setup is shown in Figure 1a. To summarize, fluid from the 
sample inlet is continuously mixed with a reagent mixture containing antibody-
functionalized beads and a phycoerythrin (PE) dye labeled affinity reagent. The resulting 
mixture incubates on chip inside the mixing stage, forming a sandwich complex with the 
target protein on the surface of the magnetic beads. It should be noted that the 
incubation/mixing stage of the device is not long enough for the antibody-modified 
microbeads to reach equilibrium with their surroundings (barring some unrealistically slow 
Figure 5. (a) A schematic showing the major features of the real time immunoassay chip. The sample 
and reagents are introduced at the appropriate inlets on the left side of the device where they then flow 
through a mixing stage. After mixing and incubation, we use a buffer suitable for fluorescent imaging to 
push the sample/reagent mixture to the top of the channel. Microfabricated nickel strips then pull the 
magnetic beads from the sample mixture into the imaging buffer where their fluorescence can be measured. 
We utilize two waste outlets so that the results can be verified on a flow cytometer after collection. (b) We 
use microfabricated nickel strips to divert paramagnetic beads from the sample solution into an imaging 
buffer. When placed on top of a neodymium magnet, the nickel strips create a strong, localized magnetic 
field. This, in turn, causes a force normal to the direction of the strips to divert beads from one buffer to 
another.  
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flow rate). Rather, we are taking advantage of the highly reproducible flow behavior inside 
microfluidic channels to ensure that the beads are all exposed to the sample for the same 
amount of time. After leaving the mixing stage, a buffer inlet forces the blood/reagent 
mixture to one side of the microfluidic channel. Due to the laminar nature of microfluidic 
flow, there is minimal mixing between the optically clear buffer and the sample mixture. 
The sample then passes over a number of microfabricated ferromagnetic strips (MFS). These 
are nickel strips 10 µm wide which have been deposited onto the glass backing wafer and 
run at an angle relative to the channel. When placed onto a permanent magnet, such as a 
neodymium magnet, the nickel strips create a large, localized magnetic field32–34. We can 
take advantage of this to displace the magnetic beads into an optically favorable buffer for 
analysis. While similar “buffer exchange” devices have been used to perform end-point 
measurements 35–38, our device is unique in that we use kinked MFS to deflect and 
temporarily trap the magnetic beads [Figure 1b]. The physics of this temporary trapping are 
relatively straightforward. If we consider a spherical particle traveling in a microfluidic 
device, there is typically only one force we need consider, that of the fluidic drag: 
𝐹𝑑⃑⃑⃑⃑ = 6𝜋𝜂𝑟(𝑣𝑓⃑⃑⃑⃑ − 𝑣𝑝⃑⃑⃑⃑ ) 
where 𝐹𝑑⃑⃑⃑⃑  is the drag force, 𝜂 is the fluid viscosity, 𝑟 is the radius of a spherical particle, 𝑣𝑓⃑⃑⃑⃑  is 
the fluid velocity and 𝑣𝑝⃑⃑⃑⃑  is the velocity of the particle. We see that a particle traveling in a 
microfluidic device will accelerate until it reaches the same velocity as the surrounding 
medium after which there will be no further net force. Upon reaching the MFS, however, 
there will be a counteracting magnetic force: 
𝐹𝑚⃑⃑ ⃑⃑  = 𝑚∇B⃑ =  
4𝜋
3
𝑀𝑟3∇?⃑?  
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where 𝑚 is the magnetic moment of the particle, ∇B⃑  is the magnetic field gradient,  𝑀 is the 
magnetization, and 𝑟 is again the radius of the particle. We see from this that the magnetic 
force will act perpendicular to the MFS strips. If the strips are at some angle (𝜃) relative to 
the flow in the device, a magnetic particle will therefore be deflected out of its path and 
move along the MFS as long as  
|𝐹𝑚| > |𝐹𝑑|sin (𝜃) 
We can take advantage of this to separate the (now fluorescently labeled) magnetic beads 
from the optically unfavorable blood/reagent mixture. In order to image the particles, 
however, we must stop or slow them down long enough to accurately measure their 
brightness. Here again we can use the MFS structures. By placing a kink at the end of the 
strips perpendicular to the direction of the flow, we now have a situation where the particles 
will be trapped so long as  
|𝐹𝑚| > |𝐹𝑑| 
4𝜋
3
𝑀𝑟3∇?⃑? >  6𝜋𝜂𝑟𝑣𝑓⃑⃑⃑⃑  
Since the magnetic field is highly localized, only particles near the nickel strips themselves 
will feel the effects of the magnetic field. As more and more particles build up behind the 
trapped beads, however, the drag force acting on the clog will continue to increase linearly 
with the size of the clog. The net effect of these two phenomena is that small clusters of 
beads will become temporarily trapped by the magnetic force counteracting the drag force. 
Eventually, depending on the flow rate inside the device, the buildup of particles behind the 
trapped beads will result in the drag force being greater than the magnetic force, pushing the 
entire cluster past the strips. We can take advantage of these kinked-MFS strips to “pause” a 
cluster of beads in place long enough to accurately image them with a CCD camera before 
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releasing them and refreshing the beads in the frame. As the footage is taken by the camera, 
the computer passes it to a real-time analysis program, allowing us to continuously quantify 
the fluorescent signal with virtually no lag time. Due to the nature of the microfluidic 
design, this entire process is inherently automated and requires minimal user input.  
 
Measuring in vitro TNFα concentration 
We first compared the results of our on-chip measurements against an analogous benchtop 
assay. Similar devices in the literature tend to incorporate multiple 'washing' steps where the 
magnetic beads are directed into a buffer stream in between protein capturing steps and 
labeling steps35–38. This increases the complexity of the device by necessitating additional 
fluidic inlets and results in a lower overall incubation time since large portions of the chip 
must be dedicated to additional sample processing. The proposed design eliminates these 
steps by incubating the antibody conjugated magnetic beads with the fluorescently labeled 
aptamer in the sample of interest at the same time. As a result, we need to know the effects 
of forming a sandwich complex in a high protein background without washing steps in 
between. We prepared serial dilutions of TNFα in PBS buffer ranging from 100 nM to 10 
pM. For the on-chip measurements, we then pumped the TNFα solution through the device 
at a rate of 0.8 ml/hr. Simultaneously, we pumped a reagent mixture containing 500 nM of 
PE-labeled anti-TNFα aptamer and a 1:500 dilution (~1x105 beads/mL) of antibody-coated 
paramagnetic beads (Dynabeads M-450) through the device at a rate of 1.2 mL/hr. Given the 
dimensions of the microfluidic channel, this flow rate corresponds to an incubation time of 
approximately 30 s. For each concentration of TNFα, we collected the sorted beads at the 
outlet and measured their fluorescence on a flow cytometer (BD FACSVerse). Between 
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runs, the chip was thoroughly washed with PBS buffer and allowed to equilibrate for 
approximately 5 min at the new TNFα concentration before performing further 
measurements [Figure 2]. Despite the short incubation time, we see the expected binding 
isotherm, indicating that we can use our device to perform quantitative measurements of 
proteins in a complex background.  
 
In order to perform real-time measurements, we need to be able to perform these 
measurements continuously. In order to do so, we developed an algorithm to measure bead 
fluorescence in real time inside of the device using a CCD camera attached to a fluorescent 
microscope. We compared the fluorescence results of samples prepared in our device and 
Figure 2. Using our device, we were able to construct a binding isotherm for TNFα. We flowed whole 
blood spiked with varying concentrations of TNFα through the device in conjunction with our reagent 
mixture, which contained antibody labeled microbeads as well as fluorescently labeled aptamer. After 
incubating for approximately 30 seconds, the MFS features passively sorted the now fluorescently labeled 
beads from the background medium, which were then collected at the outlet and analyzed with a flow 
cytometer. 
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measured with our algorithm to that of samples prepared on a more traditional benchtop 
setup and measured with a flow cytometer. We prepared the on-chip samples as above, this 
time spiking the blood with concentrations ranging from 10 pM to 100 nM. From this 
measurement, we determined that the analysis program could detect fluorescence at 
concentrations as low as 100 pM [Figure 3a]. Below this, the program could not effectively 
differentiate the beads from the background fluorescence. To validate our algorithm, we 
then compared the mean fluorescence of our traces evaluated with the algorithm to bead 
fluorescence measured with flow cytometry. We mixed various dilutions of TNFα spiked 
with the reagent mixture at a ratio of 1:1.5 and incubated for 30 min, then washed the beads 
with a PBS buffer. This mimicked the reagent ratios found in the device albeit with a much 
longer incubation time and more effective washing steps. After preparing the beads, we 
measured the median bead fluorescence at each TNFα concentration using a flow cytometer 
(BD FACSVerse). Our results show a linear correlation between the data gathered using our 
chip after a short incubation and the results gathered using a commercial device after 30 min 
of equilibration [Figure 3b].  
 
Having determined that our device could perform quantitative measurements at a reasonable 
sensitivity, we then sought to demonstrate the ability of our device to perform long term 
measurements of dynamic protein concentration changes. As before, we pumped reagents 
into the device using a Harvard Apparatus pump at 1.2 mL/hr. In order to vary the protein 
concentration as a function of time, we switched to a peristaltic pump to draw blood from 
open topped containers and pump into the device at a rate of 0.8 mL/hr. We doped whole 
blood with either 5 nM or 100 nM of TNFα and then switched inputs every 30 min, the  
  35 
 
 
Figure 3. (a) To test the sensitivity of our device and detection algorithm, we doped whole blood with 
varying concentrations of TNFα. We found that under ideal conditions we could detect concentrations as low 
as 100 pM of TNFα. Below this, the detection algorithm frequently missed beads or confused them with the 
background. The dotted lines represent the raw data while the solid lines represent a rolling average. (b) We 
then verified our results by comparing the fluorescence measured with our device/image detection algorithm 
with results from a comparable benchtop assay measured with a commercial flow cytometer 
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entire time monitoring the resulting on-chip fluorescence signal using our image detection 
program. The results of these measurements are shown in Figure 4. For such long 
measurements it became necessary to bin the data each minute and measure the average 
fluorescence of these bins in order to minimize the effect small clots and spurious beads 
becoming trapped in the device and incubating for longer than desired. We see that there is 
an approximately 5 min delay between the concentration changes and the resulting 
measurements. This is likely attributable to the dead volume from the various fluidic 
connections between the blood reservoir and the device coupled with a low overall flow rate. 
Additionally, we see that the system started to become unstable after ~85 min. At this point 
a large blood clot began blocking the channel and forcing us to halt further measurements. 
Despite these issues, we can see a clear differentiation between the low-TNFα and high-
TNFα blood, giving us an unparalleled ability to measure protein concentration changes in 
complex media in real time.  
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Figure 4. We varied the concentration of TNFα in whole blood over a period of approximately 90 
minutes and continuously measured the average fluorescence. Whole blood was pumped into the device 
from one of two open-top containers using a peristaltic pump. After a half-hour, tubing was quickly 
switched from the low TNFα to high TNFα container. At one hour, the source was switched back.  In order 
to mitigate the effect of clots and trapped beads on our data, we divided our data into 1-minute bins and 
averaged the fluorescence of each bin. After ~ 80 min a clog in the device disrupted the flow of beads 
through the channel, resulting in the termination of the experiment. 
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Materials and Methods 
Microfluidic devices: 
The microfluidic device necessary to carry out these operations was fabricated using 
standard soft lithography techniques 39,40. To briefly summarize, a mold was created by 
spinning SU8 2050 photoresist onto a clean silicon wafer and subsequently baked at 950C 
for 6 minutes. After exposing the first SU8 layer, a second layer of SU8 2015 was then spun 
onto the wafer surface. This layer is used to form the raised herringbone patterns necessary 
for the mixing stage of the device. The wafer was then baked again at 950C for 6 minutes. At 
this point, the outline of the channels was clearly visible through the thin layer of SU8 2015, 
and so we could align a second photomask with the channels and perform a second exposure 
for the same time and intensity as the first. The wafer was then baked at 950C for a third 
time before being immersed in a solution of SU8 developer. Analysis using a Dektak 
profilometer showed the channels to be 40 µm high and 500 µm wide. The MFS structures 
were fabricated by first spinning AZ 5214 photoresist onto a glass wafer. 10 µm wide MFS 
patterns were formed with a photomask by exposing the wafer to 7 mW/cm2 of UV light for 
5 seconds. The wafer was then baked at 1150C for 2 minutes before performing a second 
exposure at 7 mW/cm2 for 1 min. Afterwards, the wafer was developed in a 4:1 dilution of 
AZ 400K developer for 35 seconds. The wafer was washed and residual organic matter was 
removed using an ozone oven. 200 Å of titanium was deposited on the surface via electron 
beam deposition, followed by 1800 Å of nickel to serve as the ferromagnetic layer. The 
undeveloped areas of photoresist were then stripped by submerging the wafer in an acetone 
bath, leaving only the MFS features behind. In addition to the MFS, we deposited nickel 
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alignment marks at the same time in order to assist with aligning the microfluidic channels 
with the MFS and permanent magnet. 
To create the channels themselves, we poured polydimethylsiloxane (PDMS) on the mold 
and placed the wafer under vacuum to degas the PDMS. The wafer was then cured at 800C 
for 2 hours. In order to create a permanent bond between the PDMS and backing wafer, each 
set of channels was peeled off of the mold and placed in a Novascan PSD ozone system for 
10 minutes along with a MFS backing wafer. The channels were then aligned manually with 
the MFS features and were left overnight to bond. 
 
Analysis program: 
In order to measure the fluorescence of each magnetic bead, we wrote a MATLAB program 
to analyze bead brightness in real time [Figure 5]. The beads are imaged with a Leica 
DM4000B upright microscope with an attached CCD camera (Hamamatsu). As a first step, 
the program connects to the camera and allows the user to adjust the exposure time and 
resolution. The program then requests the user select two “regions of interest” to analyze. 
The first region contains one or more MFS and will be where the bead fluorescence is 
analyzed. The second region of interest is a control region and should not contain any MFS 
strips where beads might get trapped. This region is used to calculate a background 
fluorescence which is later subtracted from the bead fluorescence. After selecting the 
regions of interest, the program then begins to search for beads using MATLAB’s built in 
circular Hough transform function. This is a standard image processing technique. Briefly, a 
Hough transforms works by first analyzing the gradient of the image in order to identify 
edges (i.e. regions where there is a sudden shift from the dark background to a brighter 
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foreground feature such as an MFS or a fluorescent bead). For each edge pixel, the 
algorithm then evaluates whether its neighboring edge pixels fit the definition of a circle. If 
enough pixels fit the definition of a circle to pass some user-defined threshold, the algorithm 
then returns the (x,y) value corresponding to the center of the circle as well as its radius.  
 
After the circle detection algorithm returns these values for all circles detected within the 
region of interest, the program then constructs a digital “mask”, which is a matrix the same 
size as the measurement region of interest as selected by the user, but with values of 1 for 
every area where beads were recognized by the Hough transform and values of 0 otherwise. 
Figure 5. The analysis program works by feeding in video frames and analyzing a small region of 
interest selected by the user. The program searches for circles in this region (corresponding to fluorescent 
beads), and then creates a digital mask which is laid over the frame. The pixel values of the masked frame 
are integrated and then divided by the number of beads present to form an average “brightness-per-bead”, 
which is then reported to the main program. After finishing with one frame, the program then moves on to 
the most recent frame available from the camera, allowing it to analyze the data in real time at a frame rate 
of approximately 2 frames per second. 
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We then produce a filtered image by multiplying the matrix representing the current camera 
frame by the mask. This returns a filtered image matrix with non-zero pixel values 
corresponding to the brightness of each bead where circles were detected and values of zero 
otherwise. The program then sums all of the values of this filtered image and divides by the 
number of detected beads in order to give an average “brightness-per-bead” for a given 
camera frame.  
 
We noticed that when running the device for longer periods of time, ultra-bright beads 
would begin to appear, preventing the circle detection algorithm from recognizing other, less 
bright beads. Presumably, this was due to beads becoming temporarily trapped in the device 
and therefore incubating in the presence of target much longer than their companion beads 
before eventually working their way free. We used several strategies to prevent this 
phenomenon from distorting the reported data. First, the program only calculates the 
brightness-per-bead if two or more beads are detected. Second, the program keeps a bin of 
the brightness values of the most recent 50 beads. If, for a given frame, the average 
brightness-per-bead is more than three times the standard deviation of the binned beads 
away from the average brightness of the binned beads, the values of the current frame are 
considered an outlier and are not reported to the main program (although they are recorded 
in the bead brightness bin, meaning that if a large change is sustained it will be reported 
within a few frames of when it began). Finally, for time periods greater than an hour, the 
program reports the average fluorescence value over a minute-long period. While this lowers 
our time resolution, it greatly helps alleviate the effect of noise on the system.  
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Fluidic operation: 
Prior to running each experiment, the microfluidic chip was placed atop a ½”x ¼”x ⅛” 
neodymium magnet. We then prepared a fresh batch of both the reagent and buffer 
solutions. For the reagent solution, a 1:500 dilution of antibody functionalized 4.5 µm 
magnetic beads (Dynabeads) was prepared in a PBS buffer. To this was added 500 nM of 
biotinylated affinity reagent (IDT) as well as 10 mg/ml BSA and 500 nM of SAPE. The 
imaging buffer solution consisted of 2.5 mg/ml BSA in a solution of PBS and 0.25% tween-
20. Both the imaging buffer and reagent solutions were then loaded into syringes and 
interfaced with the device using 0.02” tygon tubing (Cole-Parmer). The reagent mixture was 
pumped at 1.2 ml/hr using a Harvard Apparatus syringe pump. The imaging buffer was 
likewise pumped with a Harvard Apparatus syringe pump. The optimal flow rate was 
determined at the beginning of each experiment. Depending on the precise alignment of the 
magnet with the fluidic channel, we found that this rate typically ranged between 4.5 ml/hr 
and 5 ml/hr. 
 
Human whole blood preparation: 
For measuring doped protein levels in blood, human whole blood treated with sodium citrate 
anticoagulant was ordered from Bioreclamation LLC.  Whole blood was refrigerated at 4°C 
until use. Before use, blood was warmed to room temperature and then passed through a 40-
mm pore cell strainer (Thermo Fisher Scientific) to remove any clots or aggregates which 
may have formed. Concentrated target (TNFα or F1.2) was then doped into the blood at the 
desired levels. 
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Discussion 
While there has been considerable success in recent years in creating new and highly 
sensitive immunoassays, the long and complicated sample processing steps necessary to 
make these assays work means that they are unable to offer insight into dynamic systems. 
This is unfortunate considering that there are many conditions which could be better 
diagnosed and monitored by measuring the time dependent change of the concentration of 
moderate-to-high abundance proteins. In this work, we have attempted to address this 
deficiency by designing a microfluidic chip capable of performing continuous, real-time, 
concentration measurements of medium to high abundance proteins directly in whole blood.  
 
While our device/analysis program is unable to reach the same limits of detection as 
traditional bioassays, it is capable of extremely fast measurements, allowing it to track 
concentration in real time. With a maximum time resolution of two measurements per 
second over short periods and a time resolution of one measurement per minutes over time 
periods extending over one hour, our device offers unprecedented time resolution for 
tracking concentration changes in medium to high abundance proteins. Furthermore, these 
measurements are fully automated and are performed on undiluted whole blood. Along with 
being fully automated, the system is also modular, meaning that the user need only swap out 
the affinity reagents used in order to measure a different target. Additionally, the system is 
agnostic to the type of affinity reagent used (aptamers vs monoclonal antibodies vs 
polyclonal antibodies), making it much more flexible than other systems. We hope in the 
future to expand on this work to both increase the stability of the system over long time 
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periods and to swap out the reagents in order to measure more clinically relevant targets, 
such as proteins involved in the coagulation pathway. 
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III. An electrochemical scaffold sensor for rapid syphilis diagnosis 
Introduction 
In the previous chapter, we introduced a microfluidic device designed for real-time 
monitoring of protein concentrations. While designed as a point-of-care device, this system 
still requires a continuous supply of reagents as well as extensive instrumentation (such as a 
fluorescent microscope, computer, and various pumps to operate the fluidics), and thus is 
better suited to a hospital setting where the space requirements and upfront cost are less of 
an issue. For many applications, such as disease diagnostics however, continuous 
measurements are unnecessary and instead the more important factor is the portability of the 
system, the cost, as well as the time to response. After all, the more rapidly a disease is 
diagnosed, the sooner treatment can be initiated, which improves both compliance and 
outcomes, and therefore renders it desirable to achieve diagnosis within the timeframe of a 
single patient/clinician interaction1. This is particularly true for infectious diseases, as 
single-visit diagnosis allows for the treatment of patients who would otherwise be lost to 
follow up, enabling healthcare providers to intervene immediately to change behaviors and 
limit transmission2–5. Accomplishing this, however, necessitates diagnostic tools that are 
simple enough to use at the point of care and are capable of returning answers within 
minutes rather than hours, attributes that the current, largely laboratory-centered approaches 
to molecular diagnostics fail to achieve6. 
 
The potential value of improved point-of-care diagnostics is illustrated by the “gold-
standard” approach for diagnosing syphilis, a disease for which the incidence rate has more 
than doubled in the United States during the past decade7. The current standard of care for 
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syphilis diagnosis involves two serological tests performed in sequence. The first, the 
“nontreponemal” test, detects the presence of cardiolipids associated with cell damage and is 
used to determine whether a patient has an active infection8–10. The second, “treponemal” 
test, detects antibodies specifically indicative of exposure to pathogenic bacteria from the 
Treponema genus such as Treponema pallidum pallidum, the causative agent of syphilis11. 
This two-pronged approach12 is employed because the specificity of the two individual tests 
is poor; other underlying illnesses or pregnancy can cause false positives in the non-
treponemal test and antibodies remaining from past exposure (rather than ongoing infection) 
can cause false positives in the treponemal test13,14. However, while the two-pronged 
approach improves clinical specificity, it slows down diagnosis.  Specifically, while the non-
treponemal test can be performed rapidly at the point of care using assays such as the rapid 
plasma reagin test, the treponemal test relies on traditional serological assays (e.g., 
hemagglutination, Western blotting, or enzyme linked immunosorbent assays), thus 
necessitating specialized lab facilities15,16. Given this, a rapid treponemal test capable of 
being deployed at the point of care could help to limit the spread of syphilis by eliminating 
the gap between a patient’s initial visit and a positive diagnosis, allowing clinicians to 
intervene immediately. 
 
Motivated by the general need for improved, point-of-care serological tests, we have 
recently developed a general platform for rapid (< 10 min), convenient measurement of the 
concentration of specific antibodies in unprocessed serum [Figure 1] and have adapted it 
here to the treponemal test. Electrochemical DNA (E-DNA) biosensors have already proven 
to be a versatile platform for detection of analytes in complex media such as serum17–19. 
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Here we use a modification of the E-DNA scaffold platform20, which is comprised of a 
nucleic acid duplex (“scaffold”) bound to the surface of an electrode via a flexible linker. On 
the distal end of this scaffold, a redox reporter is conjugated to one end of the DNA 
backbone, while a recognition element, such as an antigenic protein, is bound to the other. 
Binding of an antibody to the recognition element reduces the efficiency with which the 
redox reporter approaches the electrode surface, resulting in a change in electron transfer 
rate that can rapidly and conveniently be measured using standard electrochemical 
approaches.  
 
  
Figure 1. (a) E-DNA scaffold sensors are comprised of a nucleic acid “scaffold” bound to the surface 
of a gold electrode via a flexible linker (Cash et al., 2009). The distal end of the scaffold is modified with a 
redox reporter (here methylene blue; MB), and a nitrilotriacetic acid (NTA) that, in the presence of copper, 
tightly binds a hexa-his tag on the antigen (here TpN17). (b) Binding of the target antibody to the 
recognition element reduces the efficiency with which the redox reporter approaches the surface of the 
electrode, reducing the electron transfer rate and, in turn, the current observed when the sensor is 
interrogated using square wave voltammetry. 
 
 
  53 
Results 
The first step in fabricating antibody-detecting scaffold sensors is the identification of an 
appropriate antibody-recognizing epitope or antigen.  All previous examples of sensors in 
this class employed relatively short (< 18 amino acid) linear epitopes or low molecular 
weight haptens as these recognition elements20–23. Due to the difference in size between the 
recognition peptide and corresponding antibody these have the advantage of producing large 
signal gain (relative change in signal upon the addition of saturating target)24. They 
nevertheless suffer from two potentially significant limitations. First, not all antigens involve 
linear epitopes, reducing the generality of the approach. Second, not all patients seroconvert 
(i.e., generate detectable antibodies) against any given epitope. In contrast, the use of full-
length or near-full-length antigens as recognition elements supports the simultaneous 
presentation of multiple linear and conformational epitopes, which should improve clinical 
sensitivity by expanding the range of diagnostically relevant antibodies that can be detected 
and increasing the likelihood that the patient will have seroconverted for one of the epitopes 
present.  
 
In order to help determine the maximum possible size of our affinity reagent, we developed a 
Monte Carlo simulation of a scaffold sensor, allowing us to explore the effect of recognition 
element size on signal gain. The model generates a set number of scaffold conformations and, 
for each conformation in our ensemble, we individually rebuild the DNA scaffold in order to 
sample many independent conformations. To build each new scaffold the position of the first 
base pair is defined by randomly choosing a rotational angle, 𝜌, from the evenly distributed 
range 0 and 2π and an angle, 𝜃, the angle between the axis and the surface, which is randomly 
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selected from a Gaussian distribution centered on 0; the width of the Gaussian we employ 
defines the flexibility of the linker connecting the scaffold to the surface [Figure 2a].  The 
center of the base pair is then placed 6 Å from the origin along this vector, corresponding to 
the length of the carbon linker attaching the anchor strand to the surface. The position of the 
DNA backbone is then determined via appropriate coordinate transfers. For each subsequent 
base, new angles, 𝜌𝑖 and 𝜃𝑖 , (relative to the coordinates of the previous base) are randomly 
selected. The rotational angle, 𝜌𝑖, is selected from a Gaussian distribution centered on the 
average rotational angle between DNA base pairs (0.6178 radians)25 with a standard deviation 
of 0.0125, while the bend angle, 𝜃𝑖 , is selected from a distribution centered on 0 with a 
standard deviation of 
 𝜋
60
. A sphere representing the center of the next DNA base pair is placed 
3.38 Å (the per-base translation of DNA) away along this vector and the position of the 
backbone again determined. The program tracks the overall bend and twist angles and uses 
them to convert from the local coordinates (spherical coordinates calculated for each new base 
relative to the previous base) to a global Cartesian coordinate calculated relative to an origin 
located at the attachment point of the anchor to the surface. This is accomplished by first 
converting from local spherical coordinates of the nth base to local Cartesian coordinates 
relative to the (n-1)th base: 
𝑟𝑛⃑⃑  ⃑′ = [𝐿𝐵 sin(𝜃𝑛) cos(𝜌𝑛) , 𝐿𝐵 sin(𝜃𝑛) sin(𝜌𝑛) , 𝐿𝐵 cos(𝜃𝑛)]′ 
where 𝑟𝑛⃑⃑  ⃑′ is the 3x1 matrix the location of the nth base given in local Cartesian coordinates 
relative to the previous base’s reference frame, and 𝐿𝐵 is the length per base of double stranded 
DNA. We then define two rotational matrices used to convert between the local Cartesian 
coordinates and global coordinates: 
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𝑅𝜃 = [
cos (Δ𝜃) 0 sin (Δ𝜃)
0 1 0
−sin (Δ𝜃) 0 cos (Δ𝜃)
] 
𝑅𝜌 = [
cos (Δ𝜌) −sin (Δ𝜌) 0
sin (Δ𝜌) cos (Δ𝜌) 0
0 0 1
] 
where Δ𝜌 and Δ𝜃 are given by: 
Δ𝜌 =  ∑ 𝜌𝑖
𝑛−1
𝑖=1
 
Δ𝜃 =  ∑ 𝜃𝑖
𝑛−1
𝑖=1
 
From this, we can determine the position of the nth base in global coordinates centered at the 
origin, which is then: 
𝑟𝑛⃑⃑  ⃑ = 𝑅𝜃𝑅𝜌𝑟𝑛⃑⃑  ⃑
′
+ ∑ 𝑟𝑖 ⃑
𝑛−1
𝑖=1
 
This process is reiterated 27 times to create our scaffold (27 bases being the length of the 
scaffold currently employed in our experiments). Upon reaching the final base pair the 
position of the methylene blue reporter is defined by placing a sphere 7 Å away (to account 
for the size of the methylene blue and its linker) normal to one of the backbone chains. The 
“protein” is then simulated by attaching a variable radius sphere 3 Å away (to account for the 
length of the his-tag) from the opposite backbone. To simulate a flexible attachment from the 
scaffold to the protein we define an angle, , defined as the angle of the linker relative to the 
vector of the last base pair, which is randomly selected from a Gaussian distribution of varying 
standard deviation. For comparison with our experimental data we converted these radii into 
molecular weights according to the following formula26: 
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𝑅𝑔 = 7.78(𝑀)
0.37 
To build our conformational ensembles, we next determined the energy of each conformation, 
which is comprised of the internal energy of the DNA and any interaction with the surface.  
The internal energy is given by: 
𝑈𝑏𝑒𝑛𝑑 = ∑
𝑘𝑏𝑇
2 𝐿𝑝
3.38
(1 − 𝑢𝑘 ∙ 𝑢𝑘−1)
𝑛
𝑘=2
 
𝑈𝑡𝑤𝑖𝑠𝑡 = ∑
𝑘𝑏𝑇
2
𝜅(𝜌𝑘 − ?̅?)
2
𝑛
𝑘=2
 
Here 𝐿𝑝 is the persistence length of double-stranded DNA (approximated to be 53.5 nm), 𝑢𝑘 is 
the unit vector defining the kth base relative to the previous base, 𝜅 is the twist force constant 
for double-stranded DNA (203.49 radians-2)25, and (𝜌𝑘 − ?̅?) is the difference between the 
rotation angle of the kth base and the average rotational angle of double-stranded DNA. 
Interactions with the surface are defined by a hard-wall approach in which the energy of these 
interactions is zero for conformations that do not overlap with the monolayer and infinity if 
there is any overlap between the protein and the monolayer. The monolayer is simulated as an 
exclusion layer 9.25 Å from the surface. Using this potential, we used Monte Carlo approaches 
to simulate 1,000,000 conformations for each set of parameters (i.e., for each discrete value 
of   and protein radius) to generate our ensembles. 
 
Per Uzawa et al.27 we calculated a weighted mean effective electron transfer rate (𝑘𝑒𝑓𝑓) for 
each ensemble according to: 
𝑘𝑒𝑓𝑓 =
1
𝑛
∑𝑃𝑖 ∙
𝑛
𝑖=1
𝑘𝑖(𝑧) 
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here n is the number of scaffolds with non-zero probability of occurring, 𝑃𝑖 is the probability 
that the ith scaffold is in its current conformation as determined by Maxwell Boltzmann 
statistics, and 𝑘𝑖(𝑧) is a distance dependent electron transfer rate. The latter is given by a 1-D 
tunneling equation with a length constant of 1.2 Å−1  [ref28].  
 
Simulations of the scaffold sensor suggest that the dependence of the baseline peak current on 
molecular weight stems from simple geometric exclusion. Specifically, we see that the signal 
change begins to saturate when the weight of the attached recognition element corresponds to 
a radius of ~3.5 nm, which is roughly equivalent to the width of the dsDNA scaffold (~2 nm) 
plus the length of the methylene blue linker (~1 nm) [Figure 2]. We find that, besides the 
molecular weight of the attached protein, the simulated rate of electron transfer is also strongly 
dependent on the linker flexibility of the linker connecting the protein to the scaffold (𝜙), and 
the flexibility of the linker connecting the scaffold to the surface (𝜃) [Figure 2b, 2c]. Plots of 
relative estimated electron transfer rate versus recognition element molecular weight trace out 
shapes similar to those seen in experimental results24. The current suppression seen at the 
plateau, however, does not depend on the linker flexibility [Figure 2d], but rather is a function 
of the flexibility of the linker connecting the recognition element to the scaffold. This occurs 
because more flexible recognition elements can move to avoid colliding with the surface, an 
effect that presumably explains why the sensors we have characterized here, which use a 
highly flexible his-tag linker, plateau at lower signal suppression (~35% versus upwards of 
50%) than the signal suppression we have previously seen in sensors employing shorter, less 
flexible linkers20–22.  
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The above results suggest that, while the signal change induced by target binding will fall as 
the recognition element increases in size, there is nevertheless “room” to exploit larger 
recognition elements than the largest we have previously employed. As their antibody-
recognizing elements, most commercial treponemal assays employ a combination of up to 
four full-length T. pallidum membrane proteins ranging in size from 15 to 47 kDa29. 
According to our simulation results, we do not expect proteins larger than ~25 kDa to be useful 
Figure 2. (a) To help understand the behavior of E-DNA scaffold sensors, we have developed a simple 
model employing three parameters, the flexibility of the linker connecting the DNA to the surface (𝜽), the 
flexibility of the linker connecting the protein to the scaffold (𝝓), and the radius of the attached protein (𝒓). (b) 
The estimated change in electron transfer rate relative to an unmodified scaffold is a strong function of the 
recognition element size as well as the flexibility of the linker connecting it to the scaffold (where the angle 
given is the width of the distribution that 𝝓 adopts. (c) We see that the electron transfer rate is also strongly 
depended on the flexibility of the linker connecting the scaffold to the surface. (d) If we look at the change in 
electron transfer rate relative to an unmodified scaffold, however, we see that changing the surface linker 
flexibility does not affect the shape of the molecular weight gain curve. 
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as part of scaffold sensors due to the small expected signal change between the unbound state 
and the antibody bound state. Fortunately, ELISAs employing TpN17 as their sole antigen, 
however, have been shown to achieve good clinical sensitivity and specificity for the diagnosis 
of syphilis30.  Because this antigen is much larger than the largest epitopes previously 
employed in sensors of this class, we expected the resulting sensor to produce only relatively 
small gain and peak current, reducing the signal-to-noise ratio24. In response we pursued two, 
complementary methods of improving gain and signaling current.  First, we engineered our 
recombinant TpN17 protein to include only the part of TpN17 corresponding to a previously 
reported crystal structure31, reducing the protein’s molecular weight to 15 kDa. Second, we 
explored several methods of improving the scaffold’s electron transfer rate, which should lead 
to improved peak currents24. We expect from our simulations that increasing the flexibility of 
the linker between the scaffold and the surface should increase the current, even if it does not 
lead to larger signal changes upon binding. In order to verify this, we investigated three 
constructs differing in scaffold flexibility: (1) the relatively rigid, fully-double-stranded DNA 
scaffold we have used previously; (2) a peptide-nucleic-acid (PNA)/DNA hybrid scaffold, 
which we assume is more flexible based off of the conformational flexibility of PNA32; and 
(3) a double stranded DNA scaffold attached to the SAM via a flexible, 18-unit polyethylene 
glycol (PEG) linker. At each step of the fabrication process, we interrogated the sensors with 
square wave voltammetry, measured the peak current, and compared the magnitude of the 
current between constructs as normalized by the surface area of the sensing electrode [Figure 
3].  
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While the PNA/DNA scaffold provided a slightly higher peak current than the double 
stranded DNA scaffold, the PEG linker scaffold easily outperformed both, producing more 
than twice the peak current of the double-stranded DNA scaffold. Based on these results and 
on the ease of its fabrication we employed the PEG linker scaffold in our subsequent 
experiments.  
 
Figure 3. Here we compare the signaling of three sensor architectures varying in scaffold flexibility: a 
fully-double-stranded DNA scaffold (DNA/DNA), a DNA/peptide-nucleic-acid (PNA) scaffold, and a 
double stranded scaffold connected to the surface via a flexible polyethylene glycol (PEG) linker. The PEG 
DNA/DNA scaffold provides approximately twice the current (for a given sized sensor) as our previously 
employed, DNA/DNA scaffold, and thus we have employed it here. For each construct, we measured the 
peak current of nine individually fabricated electrodes and normalized each by the surface area of the 
individual electrode. 
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When tested using monoclonal anti-TpN17 antibodies we see a monotonic relationship 
between signaling current and antibody concentration. To see this, we first established a 
baseline current in buffer solutions (i.e., without antibodies present), followed by titration 
with monoclonal antibodies and recording the signal change after a 20 min equilibration at 
each concentration [Figure 4a]. Fitting the titration curve to a Langmuir isotherm yielded a 
dissociation constant of 3 nM with the signal change saturating at a gain of ~13% after 
addition of effectively saturating (20 nM) antibody [Figure 4b]. Having established that we 
could detect monoclonal antibodies in buffer, we next challenged the sensor against anti-
TpN17 monoclonal antibodies spiked into healthy (sero-negative) human serum. One of the 
chief challenges working in such a complex media is combatting non-specific adsorption of 
material to the surface of the sensor, which can cause anomalous signal changes resulting in 
baseline drift. To minimize such effects, we diluted the serum 20-fold with 1 M NaCl.  After 
Figure 4. We accomplish antibody detection through electrochemical interrogation of the sensor. (a) To 
determine the concentration of antibody present in our sample, we measure the magnitude of the peak 
methylene blue current. Here we show the electrochemical response curves in the presence and absence of 
target, which we then use to form a binding curve.  In order to account for any difference in current not due 
to the reduction of methylene blue, we used linear baseline subtraction normalize between measurements. (b) 
Upon the addition of increasing concentrations of monoclonal antibody, we observe a binding curve that is 
well fit by the expected Langmuir isotherm (R2 = 0.98). The error bars represent the standard deviation of 
three independently fabricated electrodes.  
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the addition of 100 nM monoclonal antibody the sensor effectively equilibrated within 5 min 
and the signal remained stable thereafter [Figure 5]. The signal gain we observe under these 
conditions, however, is lower than that seen in buffer. As expected, in the absence of an 
antibody challenge the sensors exhibited no significant signal change. 
 
As a demonstration of the clinical sensitivity and specificity of our platform we next 
challenged the platform with differentiating between syphilis-positive and syphilis-negative 
human serum samples. To do this we first confirmed the status of four commercially 
sourced, putatively syphilis-positive human samples and four equivalent syphilis-negative 
human samples using a commercially available ELISA [Figure 6a]. One of the syphilis-
positive patients, identified as patient 4, only responded weakly to the ELISA. Nevertheless, 
Figure 5. The sensor rapidly detects monoclonal antibody added to 1:20 diluted syphilis-negative 
human serum. Shown is the signal change seen in the absence and presence of a monoclonal anti-TnP17 
antibody. The error bars represent the standard deviation of three independently fabricated electrodes. 
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the sample absorbance was still above the cutoff threshold determined using the calibration 
samples included in the kit. This was likely a result of the patient having a low antibody 
titer, although without further information from the ELISA manufacturer regarding the 
components of their kit this is speculative. We then measured each of the eight samples 
using our electrodes in order to compare to the ELISA. For each of the patients we prepared 
electrodes and sample dilutions as described above. We then placed the electrodes into the 
sample and performed an immediate baseline current measurement followed by a second 
measurement after 10 min. In every case the signal change between these two measurements 
differentiated the syphilis-positive samples from the negative samples with good statistical 
significance [Figure 6b], including in the case of the weakly reactive by ELISA patient 4.  
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Figure 6. The E-DNA platform can detect endogenous anti-syphilis antibodies in syphilis-positive human 
serum with clinical sensitivity comparable to that of a commercial ELISA. (a) We performed an ELISA on 
human serum samples according to the manufacturer’s instructions in order to verify the infection status of 
our samples and controls. While patient four responded relatively weakly for a positive sample and negative 
four responded strongly for a negative sample, both fell within the appropriate cutoff values as defined by the 
standard samples provided in the ELISA kit. Error bars represent the standard deviation of three 
measurements. (b) We then measured the same four patients and four negative controls utilizing our scaffold 
sensor and were able to detect antibodies in all four samples, including a low-titer sample (patient 4). A 
positive control comprised of 100 nM monoclonal antibody spiked into a negative sample (negative 4) 
presents, as expected, as positive. The values presented represent the signal change after 10 min exposure, 
while the error bars represent the standard deviation of five independently manufactured sensors. 
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Materials and Methods 
Gene design, overexpression, and protein purification: 
We retrieved the nucleotide sequence encoding residues 33-156 of Treponema pallidum 
TpN17 (residue numbering from UniProt entry P29722) from the European Nucleotide 
Archive (accession ID M74825). We introduced a hexahistidine tag and two serine residues 
on the amino terminus for purification purposes, substituted Cys58 with Ser (leaving a 
unique cysteine at position 42), and codon optimized for overexpression in Escherichia coli, 
yielding the gene sequence:  
 
ATGCACCACCACCACCACCACAGCAGCGGCAAGGCGAAAGCGGAGAAGGTGGA
ATGCGCGCTGAAAGGTGGCATTTTCCGTGGTACCCTGCCGGCGGCGGACAGCCC
GGGTATTGATACCACCGTGACCTTTAACGCGGACGGCACCGCGCAGAAGGTTGA
GCTGGCGCTGGAAAAGAAAAGCGCGCCGAGCCCGCTGACCTACCGTGGTACCT
GGATGGTTCGTGAGGACGGCATCGTGGAACTGAGCCTGGTTAGCAGCGAGCAA
AGCAAGGCGCCGCACGAGAAAGAACTGTACGAACTGATTGATAGCAACAGCGT
GCGTTATATGGGTGCGCCGGGTGCGGGCAAGCCGAGCAAAGAGATGGCGCCGT
TCTATGTTCTGAAGAAAACCAAGAAATAA.  
 
Codon optimization, synthesis, subcloning into a pET-3a vector using 5′ Nde1 and 3′ 
BamH1 restriction sites, and sequencing of the final construct was performed by a 
commercial vendor (GenScript, USA). 
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We transformed the expression construct into E. coli BL21(DE3) cells (New England 
Biolabs, USA) using standard heat shock. Gene overexpression was for 5 h in lysogeny 
broth with 100 μg/mL of carbenicillin at 37°C, 220 rpm, induced by addition of 0.5 mM 
isopropyl β-D-1-thiogalactopyranoside at OD600 > 0.5. Cells were harvested by 
centrifugation and resuspended in 20 mM sodium phosphate, 40 mM imidazole, 500 mM 
NaCl, pH 7.4. Protein purification was at 4° C. Cells were lysed by ultrasonication in 
presence of DNase (Sigma-Aldrich, USA) and RNase (Roche, Switzerland). Cell debris was 
removed by centrifugation at 11,000 rpm for 1 h. TpN17 was purified from the 0.2-μm-
filtered supernatant on a HisTrap HP column (GE Life Sciences, USA), eluting the protein 
via a linear imidazole gradient up to 500 mM. Pure TpN17 fractions were identified on 
SDS-PAGE gels by SafeStain staining (Thermo Fisher, USA) and dialyzed into 1x 
phosphate buffered saline (PBS), pH 7.4 (Sigma-Aldrich, USA), and protein concentration 
was determined by UV/visible spectroscopy.  
 
Sensor fabrication: 
Gold disc electrodes (2 mm diameter) were first mechanically polished in both a 1 µm 
diamond and a 0.05 µm aluminum oxide slurry, followed by electrochemical cleaning by 
successive cycling in both 0.5 M NaOH and 0.5 M H2SO4. An anchor DNA strand which 
had been thiol and methylene blue (MB) modified (HS(CH2)6-CAG TCA GTC AGT CAG 
TCA GTC AGT-MB)) was reduced in a 10 mM TCEP solution for 1 h before being diluted 
to a working concentration of 16 nM in 1xPBS. The DNA sequence used for the anchor 
strand is the same as our group has used previously for other scaffold-type sensors20-24. We 
originally chose this sequence because it was predicted not to interact with itself, thus 
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preventing binding of the complement strand, and our group’s success using this sequence 
as an anchor strand supports this prediction. Electrodes were incubated in the DNA anchor 
solution for 1 h and then rinsed briefly with deionized water. We next coated any remaining 
exposed gold on the electrode with a protective alkane-thiol monolayer by immersing them 
in a 10 mM solution of 6-mercapto-1-hexanol overnight at 4° C.  
 
Successful deposition of both the monolayer and anchor strand was confirmed by placing 
the electrodes in a 1x PBS solution and measuring the methylene blue reduction peak with 
square wave voltammetry using a 25 mV, 60 Hz, signal. A nitrilotriacetic acid (NTA)-
modified complimentary DNA strand was then diluted to 100 nM and the electrodes 
incubated in this solution for 30 min. Binding of the complementary DNA was verified by 
measuring the reduction in magnitude of the MB peak. Following this, TpN17 was bound to 
the assembled scaffold using a His-NTA complex. The electrodes were incubated in a 100 
µM CuSO4 solution in 1x PBS for 15 min. After this, a 15 µL drop of 10 µM His-tagged 
TpN17 was placed on the tip of the electrode and incubated for 45 min. The resulting 
sensors were rinsed, and the attachment of the protein verified by again scanning using 
square wave voltammetry.  
 
Electrochemical measurements: 
Comparative measurements of the anchor strands were performed in 1x PBS buffer. We 
prepared three electrodes for each of our constructs (DNA/DNA, PEG-DNA/DNA, 
DNA/PNA). Prior to depositing the anchor strand, we determined the surface area of each 
electrode by immersing the electrodes into 0.05 M H2SO4 and measuring the area the gold 
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oxide reduction peak. After depositing the anchor strands and forming the alkane-thiol 
monolayer, we used square wave voltammetry (60 Hz, 25 mV signal) to measure the 
methylene blue reduction peak of each construct, using a linear baseline subtraction to 
account for any current difference between the more positive and more negative sides of the 
potential window. We then measured the signal reduction after adding in the complementary 
NTA-labeled oligonucleotide for each electrode as well as the signal reduction due to the 
addition of the TpN17 protein. Finally, we added 100 nM of mouse monoclonal anti-TpN 17 
antibodies (Clone B1707M, Catalog # MBS319589, MyBioSource, USA) in order to verify 
that the signal change due to saturating antibody concentrations remained constant amongst 
all of the sensor constructs.    
 
As with the anchor strand measurements, we performed the antibody titrations in 1x PBS. 
We began by measuring the baseline methylene blue peak current for three electrodes. 
Monoclonal antibodies were then added every subsequent 20 min and the reduction in peak 
current measured. In order to verify that the signal change was not due to degradation of the 
sensor over time, three additional electrodes were prepared and measurements in 1x PBS 
(without the addition of antibodies) were performed contemporaneously with the titration 
measurements.     
 
For measurements of clinical samples, human serum samples for both healthy and syphilis 
positive patients were obtained from a commercial source (Bioreclamation IVT, USA). The 
infection status of each of the positive patients was confirmed via a rapid plasma regain test 
by the vendor. Serum measurements were performed by first diluting samples into their 
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appropriate buffers and then placing sensors in a dilute serum solution and immediately 
beginning to scan using square wave voltammetry at a 25 mV amplitude and 30 Hz. ELISAs 
(Zeus Scientific, USA) were purchased and measurements performed according to 
manufacturer’s instructions. 
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Discussion 
 
Here we have shown that an E-DNA scaffold sensor employing a near-full-length antigen as 
its recognition element can detect diagnostically relevant antibodies at clinically relevant 
concentrations in human serum samples. Despite the relatively large size of the antigenic 
protein it employs, this new treponemal test easily differentiates syphilis positive human 
serum samples from those of healthy control patients in as little as ten minutes via a simple 
assay that requires no reagents other than the dilution buffer. The clinical sensitivity of the 
test compares favorably to that a commercially available ELISA, one of the current gold 
standards for serological diagnosis of syphilis, while taking a fraction of the time (minutes 
as opposed to hours) and being far less complex (far fewer steps) to perform. 
 
Given that not all patients will produce antibodies against any single epitope and that many 
antibodies recognize conformational rather than linear epitopes, the use of a folded antigen 
as our recognition element expands the potential range of diseases that can be diagnosed 
using sensors in this class and opens the door for a more general platform which can be used 
to adapt established clinical assays into point-of-care tests. This increase in generality, 
however, comes at the cost of signal gain. Working in buffer solutions we have previously 
established that recognition elements up to ~25 kDa in size can produce appreciable signal 
change upon binding. While our results in buffer are in line with this observation, our results 
from serum samples lead us to believe that biofouling and the associated loss in signal 
change might reduce the maximum possible size of the recognition element for scaffold 
sensors operating in complex media closer to 15 kDa, although a more rigorous study of this 
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effect would be needed. Even with this restriction in mind, this proof of principle opens the 
door to a wide range of potentially useful full-length and near full-length antigen E-DNA 
sensors based off of this platform, and the precise molecular-weight-limit is likely to depend 
on the specific geometry of the antibody-antigen complex. 
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IV. Towards the rational optimization of aptamers for electrochemical 
sensors 
 
Introduction 
 
Aptamers are short (typically 20 to 70 bases), oligonucleotides that are capable of binding to 
a non-nucleic acid target such as a protein or small molecule1,2. Typically, they have regions 
of self-complementary bases which help define a three-dimensional structure able to bind to 
the target of interest3–5. In the absence of target, however, the three-dimensional structure is 
often unstable, leading to a phenomenon where aptamers can undergo large conformational 
changes between the “bound” and “unbound” states. A major recent advance in sensing has 
been to take advantage of these conformational changes to couple target binding with an 
easily measurable output6–13. One such method is to modify the aptamer with a redox active 
“reporter”, such as methylene blue (MB), and then tether the aptamer to an electrode. In the 
unbound state, the aptamer is unfolded and the redox reporter is far from the surface, 
resulting in slow electron transfer when interrogated. In the presence of target, however, the 
Figure 1. Cartoon schematic showing the basic operation of an electronic aptamer based sensor. In 
the absence of target, the aptamer is in an unstructured state and the average electron transfer rate between 
the methylene blue molecule and the surface is low. In the presence of target, however, the aptamer’s 
structure is stabilized, bringing the methylene blue closer to the surface and increasing the electron transfer 
rate. This change in electron transfer rate can be measured using standard electrochemical methods such 
as square wave voltammetry or chronoamperometry 
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three-dimensional structure is stabilized, locking the redox reporter into a position closer to 
the surface and thereby increasing the electron transfer rate [Figure 1].   
 
While this modification strategy sounds simple in concept, not all aptamers are amenable to 
being transformed into a sensor in such a fashion. It is, therefore, common practice upon 
receiving a new aptamer sequence to then “engineer” it for use as a sensor14,15. Depending 
on the structure of the folded state, it may be necessary to move the redox reporter to 
different locations along the aptamer in order to maximize the difference in electron transfer 
rate between the two states. Alternatively, a researcher might find that the folded state is 
stable when conjugated to the surface, reducing the signal change seen upon target binding. 
In this case, a researcher may choose to truncate complementary regions in the aptamer in 
order to destabilize it or to split the aptamer in two connected with a flexible linker16–18. As 
another strategy, a researcher might attempt to add non-complementary bases before or after 
complementary regions in order to shift the entire aptamer away from the surface15. This 
may be done for several reasons, including attempting to engineer a larger difference in 
electron transfer rate between the bound and unbound states, attempting to move the binding 
pocket away from the surface and therefore give it greater access to the analyte, and 
attempting to minimize disruptive surface effects on the aptamer. A major challenge when 
developing aptamer-based sensors is therefore determining which modifications to make to 
the aptamer in order to maximize the difference between the electron transfer rates of the 
bound and unbound states without sacrificing affinity for the target. 
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While “engineering” implies a careful and scientific approach, in reality this process is semi- 
(or fully) empirical. Specifically, there has been little effort to systematically explore and 
understand the physical effects of any of these modifications. Rather, individual researchers 
typically just order and test a variety of constructs then select the best performing varient. 
While this may make sense on an individual level, it would be preferable in the long term to 
construct a predictive model capable describing the effects of aptamer modifications on 
sensor behavior. Unfortunately, developing a complete model of an aptamer interacting with 
its target is an difficult. Given the vast diversity of possible aptamer targets, including 
everything from small molecule drugs weighing a few dozen daltons to proteins weighing 
nearly one hundred kilodaltons, there is no single computational method appropriate for 
simulating the interaction of a generic aptamer with its target. Indeed, if such a model was 
available, it would be possible to perform aptamer selection completely in-silico, rendering 
traditional methods entirely unnecessary. Here, instead, we will focus on the much more 
acheivalbe task of isolating one possible modification strategy, in this case the addition of 
non-complementary bases on the 3’ and 5’ ends of the aptamer, and simulating the resulting 
effect on the electron transfer rate of the aptamer in its bound and unbound states.  
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Results 
 
In order to compare the bound versus the unbound states, we have constructed a kinetic 
Monte Carlo model of a “generic” aptamer system. The model divides our simulation into 
two separate programs, one which addresses the behavior of the unfolded state and one 
which addresses the behavior of the folded state. In doing so, we can compare the behavior 
of the aptamer in the absence of any target and in the presence of saturating amount of 
target. Here we are making the implicit assumption that the folded structure is sufficiently 
unstable in the absence of target that no aptamers are in this conformation unless stabilized 
by the target. Likewise, we assume that the folded state is sufficiently stable such that in the 
presence of saturating amounts of target the bound state will retain its structure over time 
periods significantly longer than the amount of time being simulated (the timescale of the 
simulations, which is defined by the slower electron transfer rate, is typically of the order of 
seconds). While with real sensors we will never experience a situation where all of the 
aptamers on a surface are in the bound or unbound conformations, optimizing the difference 
in electron transfer rate between these two states remains the best way to maximize signal 
gain. Additionally, despite not entirely representing the conditions on the sensor surface, 
these assumptions are in good agreement with empirical observations of the aptamer 
systems which our lab has encountered thus far. For instance, one available aptamer 
explored by our group is an aptamer against the chemotherapy drug doxorubicin. If we 
interrogate a surface bound doxorubicin aptamer with square wave voltammetry, can graph a 
Lovric plot showing the peak electric charge versus the applied frequency, which gives us a 
rough estimate of the distribution of electron transfer frequencies for the doxorubicin 
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aptamer [Figure 2]. After adding 100 µM of doxorubicin, we can clearly see that both the 
bound and unbound states have distinctly different peak electron transfer rates. This 
indicates that there is minimal contribution from unfolded and folded states respectively and 
that we may safely divide our task into two separate programs.  
 
We gain several advantages by dividing the simulation into models of the two distinct states, 
chiefly in being able to greatly simplify each model. First, we do not need to add specific 
logic to address the interaction of the target with the aptamer. This is a poorly studied field 
and, to our knowledge, there are only a few DNA aptamer/target pairs which have been 
studied with crystallography19–24. Thus, due to our dividing of the models, we can avoid all 
uncertainties related to whether the target interacts with the bound or unbound stage, what 
specific orientation of the target relative to the aptamer is needed in order to bind, et cetera, 
while still being able to extract useful information for optimizing other aspects of the 
aptamer design. This simplification also allows us to avoid explicitly modeling base-pair 
Figure 2 Lovric plots of the doxorubicin aptamer show the distribution of electron transfer rates in our 
system. Shown here are plots in the absence of target (a) and presence of saturating amounts of target (b). 
We see two distinctly different distributions, indicating that each state has distinct electron transfer behavior. 
It should be noted that the sudden signal drop around 100 Hz is due to an equipment artifact. 
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interactions, a time and resource intensive task with little bearing on the modification 
strategy being considered. Instead, we can “fix” the conformation of certain base pairs to 
ensure they are properly hydrogen bonded. We then assume that the rest of the bases do not 
interact. 
 
With our general strategy in mind, we begin by examining the simpler problem, modeling 
the unbound, unfolded state. This consists of a single strand of DNA anchored to a surface 
and with a redox reporter conjugated to the last base. We will use a similar Monte Carlo 
approach as described in the previous chapter, albeit with modifications to reflect our 
current system. To initialize the system, we start the simulation in the lowest possible energy 
state, a strand of DNA of length n bases that extends straight up from the surface. For a set 
number of steps, we apply a small deviation to the position of each of the n bases and 
calculate the energy associated with such a deviation. These deviations are made in spherical 
coordinates relative to the reference frame of the base previous and the magnitude is chosen 
such that the bend energy equilibrates around  
3
2
𝑘𝐵𝑇. Here we model the DNA as a freely 
jointed chain which has a bending energy given by: 
𝐸𝐹𝐽𝐶 ≅ 𝑘𝐵𝑇 (
𝐿𝑝
𝐿𝑏
) (1 − cos(𝜙)) 
where Lp is the persistence length of single stranded DNA (~2.2 nm), Lb is the length per 
base (~0.676 nm) [ref25] and 𝜙 is the bend angle between two bases. If the change in energy 
associated with the move is less than zero, the deviation for that base is accepted, while if 
the energy is greater than zero the change is accepted with a probability  
𝑃 = 𝑒
Δ𝐸
𝑘𝐵𝑇 
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We then update the global position of all the bases based off of the spherical coordinates of 
each base calculated relative to the previous base. This process proceeds in much the same 
fashion as described in the previous chapter. We model the self-assembled monolayer on the 
surface of our electrode as a hard exclusion zone lying on the z = 0 plane. After updating the 
positions, we check that all the bases lie above this plane and, if not, we attempt to resolve 
this conflict by relaxing the most recent deviation to the system. The program recalculates 
the positions with a deviation 95% of the magnitude of the original deviation and then 
rechecks for bases lying below the monolayer. This process is repeated iteratively until no 
conflicts are observed. Once we have achieved this, we calculate the effects of the electric 
potential of the surface on the DNA. Here we treat the electric potential as a decaying 
exponential due to screening of the applied voltage by electrolytes in solution: 
𝑉(𝑧) = 𝑉0𝑒
−
𝑧
𝜅 
where  𝑉0 is the voltage at the surface, equal to the reduction potential of methylene blue (-
0.35 V), and 𝜅 is the Debye length in a 150 mM electrolyte solution (~0.785 nm). We then 
calculate a Δ𝑈𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑠𝑡𝑎𝑡𝑖𝑐 for each base based off the proposed position of the DNA bases 
compared to the starting position of the DNA bases. Based off this second energy 
calculation, we then use the Monte Carlo algorithm to reevaluate whether to accept or reject 
the change in position.  
 
Once we have iterated through each DNA base in this fashion, we have completed one step 
in the Monte Carlo algorithm and have a new conformation for our DNA. These Monte 
Carlo steps do not inherently give us any information about the amount of time which has 
elapsed, however, making it impossible to calculate an electron transfer rate. In order to 
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account for this, we introduce the “kinetic” portion of our kinetic Monte Carlo algorithm. In 
order to do so, we assign time values to each of our steps by measuring the distance that the 
terminal base has traveled. We then use the diffusion equation to calculate the approximate 
amount of time it would take to diffuse such as distance: 
< Δ𝑥2 > = 6𝐷Δ𝑡 
where D is the length dependent diffusion rate of single stranded DNA as empirically 
measured by Robertson et al.26: 
𝐷 =  3.096 ∗ 10−8(𝑁𝑏𝑎𝑠𝑒𝑠)
−0.571 
here the diffusion rate is given in units of 
𝑛𝑚2
𝑠
 and 𝑁𝑏𝑎𝑠𝑒𝑠 is the length of the single stranded 
DNA. We then can determine whether an electron was transferred between the redox 
reporter and the surface by calculating the distance between the last base (which we assume 
to hold the redox reporter) and the surface. We calculate the probability of an electron being 
transferred as the amount of time elapsed multiplied by the probability of an electron being 
transferred in that conformation according to a 1-D long distance tunneling equation: 
𝑃𝑒𝑇 = 𝑘𝑒𝑇Δ𝑡 = 4400𝑒
−1.2∗𝑧𝑟𝑒𝑑𝑜𝑥  Δ𝑡 
where we have chosen the prefactors for the tunneling equation in accordance with 
experimental values for methylene blue in 150 mM phosphate buffered saline27.   
 
For the structured, bound aptamer state, we use a modified version of the single stranded 
DNA algorithm. Instead of inputting a single overall aptamer length, we now have two 
inputs, a “stem” length and a “tail” length corresponding to the number of bases added at the 
3’ or 5’ end before and after the double stranded region of the structured aptamer. It should 
be noted that the model does not explicitly address the structure of the “loop” portion of the 
  85 
aptamer. We believe this to be an acceptable generalization because, since the loop portion 
of the aptamer must begin and end connected to the same double stranded portion of the 
aptamer, the final position of the methylene blue is not affected by the conformation of the 
loop or the interaction of the target with the aptamer. Thus, we only have to simulate the 
region around the stem of the aptamer and can avoid explicitly simulating the loop. To 
demonstrate this experimentally, we once again turn to measuring the electron transfer rate 
of the doxorubicin aptamer, this time with varying lengths of poly-thymine introduced in the 
loop portion of the aptamer. After inserting either 10 or 30 thymine bases in the loop portion 
of the aptamer, we see that the electron transfer rate of the bound state stays the same while 
the electron transfer rate of the unbound state decreases as the aptamer is made longer 
[Figure 3]. This simplification allows us to avoid explicitly addressing the interaction of the 
target with the binding pocket in our simulation. Instead, we proceed in much the same 
fashion as the single stranded simulation up to the length of the stem portion. Once the 
algorithm reaches the final ‘stem” base, it then calculates the position of a complementary 
base, which is assigned as the position of the first “tail” base. The algorithm then continues; 
now calculating distances in the opposite direction, until it reaches the final “tail” base. In 
doing so, we can calculate the position of the final base, and therefore the redox reporter, 
without explicitly calculating the position of the loop. The diffusion constant is calculated as 
the harmonic mean between the diffusion constant of a section double stranded DNA whose 
length corresponds to the length of the unmodified aptamer and the diffusion constant of the 
single stranded additions made to the aptamer before and after the stem-loop.  
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We find that our Monte Carlo model is able to correctly predict the relationship between the 
electron transfer rate for varying lengths of  single stranded DNA. We predict that the 
electron transfer rate should scale with the length of the aptamer with a power law 
dependence of −1.61 ± 0.39 while experimental data shows a power law dependence of 
−2.2 ± 0.3 [ref28]. These results are within the margin of error of one another, indicating 
that our model is able to sufficiently describe the behavior of the open state [Figure 4]. 
 
Figure 3 (a) Lovric plots of the doxorubicin aptamer with varying lengths of poly-T inserted in the loop 
portion of the aptamer show that in the absence of target the electron transfer rate slows as the aptamer is 
lengthened. Here purple is the native aptamer, green is the aptamer with 10 thymine bases inserted, and blue 
is the aptamer with 30 thymine bases inserted. (b) While changing the loop portion of the aptamer predictably 
causes large changes in the electron transfer rate, in the folded state we see little difference between the native 
aptamer (purple), the aptamer with 10 poly-T (green), and with 30 poly-T (blue). 
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For the closed state of the “aptamer”, we chose to investigate the effects of adding bases 
before and after the stem portion of the aptamer. This one of several strategies employed in 
engineering aptamers in an attempt to improve signal gain. The expectation is that while this 
will move the binding pocked farther from the surface, potentially allowing the aptamer to 
better bind with its target, it will also lead to slower electron transfer in the bound state. 
Since the signal change is dependent on the difference between the states, however, it is 
possible to achieve better overall performance despite slower rates in the closed state as long 
as the electron transfer rate of the open state decreases more quickly than that of the closed 
state. Specifically, we will examine one modification strategies in which we add bases both 
Figure 4 A comparison of the simulated electron transfer rate (black) with data measured via 
chronoamperometry (red) shows good agreement between our model and experimental results for 
unstructured, unbound, DNA  
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before and after the stem with the goal of balancing out the detrimental effect of adding 
bases before the stem.  
 
From the simulations, we see a noticeable difference between the symmetric and asymmetric 
cases. Plotted below is the simulated electron transfer rate for the unfolded state versus the 
electron transfer rate of asymmetrically and symmetrically modified aptamers with a 25-
base loop [Figure 5]. As further bases are added around the stem, it increases the length of 
the aptamer in the unfolded state as well. It is therefore possible to gain a rough estimate of 
the performance of an aptamer construct by drawing a vertical line at a given total base 
length and taking the difference between the electron transfer rate of the unfolded state and 
one of the two competing folded states. Because the model assumes one base is present after 
the stem loop, we see that initially the symmetric and asymmetric cases are the same and 
only differ slightly due to noise arising from the random fluctuations due to the nature of the 
Monte Carlo simulation. As the number of additional bases grows, however, we see that the 
electron transfer rate of the asymmetric case falls off more rapidly than the symmetric case, 
likely due to the symmetric case allowing for more states where the redox reporter is able to 
approach the surface. Eventually, however, the gap between the asymmetric and symmetric 
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states narrows before vanishing all together after adding approximately 16 bases to the 
original stem-loop. It is worth noting that the electron transfer rate of both cases decreases 
faster than that of the unfolded aptamer, indicating that all modifications of this sort will 
have a negative effect on the observed signal change. If a researcher wishes to perform such 
a modification on their construct for reasons other than changing the electron transfer rate 
(such as moving the binding pocket away from the electrode surface), then this model 
advises that such modifications should be kept as short as possible in order to minimize the 
negative effect they will have on the electron transfer rate.  
Figure 5. As we add bases to the stem loop, we see that regardless of modification strategy the 
electron transfer rate of the closed state falls off faster than the electron transfer rate of the open state. Here 
the dotted line represents the simulated electron transfer rate of an aptamer in the unbound state, while the 
solid line represents the electron transfer rate of the bound state. Experimental date is shown as solid dots 
where the error bars represent the uncertainty of the exponential decay fit. 
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In order to confirm the accuracy of our model, we ordered a series of stem-loop DNA 
constructs to stand in for a generic “aptamer”. Each construct maintained the same 25-base 
“structured” region consisting of 5 complementary bases forming the stem with 15 non-
complementary bases forming the loop. The sequence itself was chosen off past studies 
which have shown this sequence to be highly stable at room temperature29. We then added 
varying numbers of thymine bases on either the 3’ or on the 3’ and 5’ ends of the stem in a 
manner consistent with simulated structure from our Monte Carlo model. We measured the 
electron transfer rate for each sequence using chronoamperometry and compared it against 
the electron transfer rate of the simulated model [Figure 5]. We found our experimental 
results to be in good agreement with the simulations, thus validating our approach.    
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Materials and Methods 
 
Simulations: 
Simulations were performed using a custom MATLAB script the details of which are given 
above. The code itself is provided in Appendix B. For each data point, the program was 
allowed to run until it measured 100 electron transfer events, at which point it reported the 
total elapsed time. The electron transfer rate was then simply calculated as the number of 
electrons transferred divided by the elapsed time.  
 
Electrode fabrication: 
To confirm the results of our simulation, we performed electrochemical measurements of the 
electron transfer rate of a step-loop construct. We began by polishing 2 mm diameter gold 
disc electrodes in a 1 µm diamond slurry followed by polishing in a 0.05 µm aluminum 
oxide slurry. The electrodes were then electrochemically cleaned by successive cycling in 
both 0.5 M NaOH and 0.5 M H2SO4. For doxorubicin measurements, we used an aptamer 
with the following sequence as the parent aptamer: 5’ - ACC ATC TGT GTA AGG nT 
GGT AAG GGG TGG T – 3’ where nT represents varying lengths of poly-thymine. To 
simulate aptamers in their folded conformation, we conjugated closed stem loops with 
various modifications made to the 3’ and 5’ end to our electrodes. The various constructs all 
contained a thiol group and a methylene blue (MB) modification and followed the same 
sequence (nT- TCG CGC GAT CGG CGT TTT AGC GCG T-nT) where nT represents 
varying lengths of poly-thymine. Constructs were reduced in a 10 mM TCEP solution for 1 
h then diluted to a concentration of 100 nM in 1xPBS. This sequence was chosen because it 
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has previously been shown to form stable stem-loops. We incubated the electrodes in the 
stem-loop solution for 1 h and then rinsed briefly with deionized water. To protect the 
surface of the electrode, we then immersing them in a 10 mM solution of 6-mercapto-1-
hexanol overnight at 4° C, coating any remaining exposed gold on the electrode with an 
alkane-thiol monolayer. 
 
Electrochemical measurements: 
We used Lovric plots were to illustrate the difference between the electron transfer behavior 
of the bound versus unbound states. To perform these measurements, we scanned electrodes 
with square wave voltammetry (using a custom script written for a CH instruments 
potentiostat) for a set number of frequencies and then extracted the peak current observed at 
each. The Lovric plots were then constructed by dividing the peak current by the frequency 
being measured. While these measurements are easy to perform and analyze, due to the low 
frequency resolution of the Lovric plots, we chose to use chronoamperometry to better 
determine the electron transfer rate of the stem-loop constructs for comparing to our model. 
For these measurements, after successfully modifying the gold electrodes, we performed a 
cyclic voltammetry sweep from -0.1 V to -0.4 V in order to confirm the presence of the 
methylene blue modified DNA on the surface and to determine the precise voltages to be 
used during the chronoamperometry portion of the experiment. We then began the 
chronoamperometry sweep with the methylene blue in a fully oxidized state before jumping 
to a reducing potential as determined by the cyclic voltammetry scan and measuring the 
resulting current decay. Due to limitations of the instrument, in order to capture the full 
current decay we performed three measurements at varying sensitivities and used a custom 
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MATLAB script to reconstruct the full decay [Figure 5]. To reduce noise, each measurement 
was repeated 50 times and the average current decay was used to extract the electron transfer 
rate. We fit the portion of the decay corresponding to the methylene blue reduction to a 
single exponential decay, allowing us to extract the electron transfer rate for each stem-loop 
construct.  
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Conclusion 
 
Adapting aptamers to be used in sensors is a laborious and expensive task which depends 
largely on trial and error. In an attempt to help streamline this task, we have developed a 
Monte Carlo model which simulates the electron transfer rate of a generic aptamer and 
examines how modifications to the aptamer might affect the difference in electron transfer 
rates between the bound and unbound states. To validate our model, we examined how the 
addition of poly-thymine at the 3’ and 5’ ends of an aptamer influences the performance of 
the resulting sensor. Our simulation shows that the addition of poly-thymine reduces the 
electron transfer rate of the bound state by a larger degree than that of the unbound state. 
This indicates that such a modification strategy would not improve the performance of a 
sensor, but rather would actually make it worse. This is backed up by experimental evidence 
which shows that for a stem-loop construct with varying lengths of poly-thymine added 
around the 3’ and 5’ ends we see a similar effect, albeit with far fewer data points to define 
the shape of the curve.  
 
As electrochemical DNA based sensors mature, it will become increasingly important to 
understand the physics behind how they work in order to better optimize them for specific 
applications. While experimental evidence will always be necessary to validate 
computational models, to perform the full equivalent experiment to our simulations, we 
would have had to design, purchase, and evaluate approximately 20 DNA sequences. Such a 
task would have taken weeks to months to complete as opposed to the few hours required to 
run our program. Thus, while models such as ours cannot entirely replace benchtop 
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measurements, they can be used to help identify promising paths forwards and help avoid 
wasting time and resources on unrewarding or unlikely to succeed strategies.  
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Appendix A: Real-time video analysis 
% Code for performing real-time analysis of fluorescence in microfluidic 
% channel (Chapter II) 
function [dat,top_dat,time,background] = vid_analysis8(numbframe,numbroi) 
close all 
%Initialize Camera 
delete(imaqfind); 
vidobj = videoinput('hamamatsu',1,'MONO16_1344x1024'); 
src = getselectedsource(vidobj); 
%Set initial values  
set(src,'ExposureTime',0.2) 
set(vidobj, 'FramesPerTrigger', 1); 
set(vidobj, 'TriggerRepeat', Inf); 
triggerconfig(vidobj, 'manual'); 
  
%Take a snap shot to set ROI 
preview(vidobj); 
rawsnap = getsnapshot(vidobj); 
snap = imadjust(rawsnap); 
imshow(snap); 
[matrix_of_roi] = selectROImask(snap,numbroi); 
backgroundroi = selectbackground(rawsnap,snap); 
  
%Start live(-ish) video analysis 
start(vidobj); 
[dat,top_dat,time,background] = 
analyze_frames(vidobj,matrix_of_roi,numbframe,numbroi,backgroundroi); 
stop(vidobj); 
end 
  
  
%ROI function 
function [matrix] = selectROImask(movie_frame_in,num) 
%Specify Region of Interest 
ROI_img = imshow(movie_frame_in); 
matrix = zeros(num,4); 
%Zoom in (press enter to finish zooming) 
zoom on; 
waitfor(gcf,'CurrentCharacter',char(13)) 
  
%Select a rectangular region (double click to select) 
rec_selec = imrect; 
chec = wait(rec_selec); 
pos = getPosition(rec_selec); 
  
matrix(1,1) = pos(1); %Xmin 
matrix(1,2) = pos(2); %Ymin 
matrix(1,3) = matrix(1,1)+pos(3); %Xmax 
matrix(1,4) = matrix(1,2)+pos(4); %Ymax 
  
for ii = 2:num 
    rec_selec = imrect; 
    position = wait(rec_selec); 
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    matrix(ii,1) = position(1); %Xmin 
    matrix(ii,2) = position(2); %Ymin 
    matrix(ii,3) = matrix(ii,1)+pos(3); %Xmax 
    matrix(ii,4) = matrix(ii,2)+pos(4); %Ymax 
    %ii = ii+1; 
end 
close all 
end 
  
function backbrightroi = selectbackground(~,adjusted_frame_in) 
ROI_img = imshow(adjusted_frame_in); 
zoom on; 
waitfor(gcf,'CurrentCharacter',char(13)) 
backbrightroi = zeros(1,4); 
%Select a rectangular region (double click to select) 
rec_selec = imrect; 
chec = wait(rec_selec); 
pos = getPosition(rec_selec); 
backbrightroi(1,1) = pos(1); %Xmin 
backbrightroi(1,2) = pos(2); %Ymin 
backbrightroi(1,3) = backbrightroi(1,1)+pos(3); %Xmax 
backbrightroi(1,4) = backbrightroi(1,2)+pos(4); %Ymax 
end 
  
  
function [all_centers,radii,beads] = 
o_detect_outliers(videoframe,modframe) 
    %Modified version of o_detect which removes outliers and returns same 
radius for all. Output includes 
    %all circle detect data and the average brighness 
    [centers,~] = imfindcircles(videoframe,[6 
13],'ObjectPolarity','bright','Sensitivity',0.90,'Method','TwoStage'); 
    [centers2,~] = imfindcircles(videoframe,[6 
11],'ObjectPolarity','dark','Sensitivity',0.80,'Method','TwoStage'); 
     
    %Establish coordinate grid 
    [x,y]= meshgrid(1:size(modframe,2),1:size(modframe,1)); 
     
    %create array to hold bead brightness data 
    all_centers = cat(1,centers,centers2); 
    dimens = size(all_centers); 
    numtotal = dimens(1); 
    beads = zeros(1,numtotal);  
    radii = zeros(1,numtotal); 
     
    if numtotal <= 1 
        beads(beads==0) = NaN; 
        radii = zeros(1,numtotal) + 7; 
        
    else 
  
        for jj=1:numtotal; 
            mask_temp = zeros(size(modframe)); 
            xc = all_centers(jj,1); 
            yc = all_centers(jj,2); 
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            radii(jj) = 7; 
            mask_temp = (x-xc).^2 + (y-yc).^2 < 49; 
            filt = videoframe.*uint16(mask_temp); 
            beads(jj) = sum(sum(filt)); 
        end 
    end 
end 
  
  
  
function 
[corrected_avgbright,corrected_topval,corrected_times,background4later] = 
analyze_frames(objinput,roi_matrix,numframes,numroi,backroi) 
  
%Reserve some memory 
avgbright = zeros(numframes,1); 
avgtopvalues = zeros(numframes,1); 
times = zeros(numframes,1); 
captionFontSize = 14; 
bead_buffer = zeros(50,1); 
bead_buffer(bead_buffer==0)=NaN; 
background4later = zeros(numframes,1); 
%Cycle through frames 
ii=2; 
waitfor(gcf,'CurrentCharacter',char(13)) 
while double(get(gcf,'CurrentCharacter'))~=27 
 tic 
    %Filter out everything but ROI and find the edges 
    trigger(objinput); 
    big_img = getdata(objinput); 
    ymin1 = roi_matrix(1,2); 
    ymax1 = roi_matrix(1,4); 
    xmin1 = roi_matrix(1,1); 
    xmax1 = roi_matrix(1,3); 
    originalImage = big_img(ymin1:ymax1,xmin1:xmax1); 
    for jj = 2:numroi 
        ymin = roi_matrix(jj,2); 
        ymax = roi_matrix(jj,4); 
        xmin = roi_matrix(jj,1); 
        xmax = roi_matrix(jj,3); 
        temp_img = big_img(ymin:ymax,xmin:xmax); 
        originalImage = cat(2,originalImage,temp_img); 
        %jj = jj+1; 
    end 
     
    %Measure background signal for later normalization 
    backymin = round(backroi(1,2)); 
    backymax = round(backroi(1,4)); 
    backxmin = round(backroi(1,1)); 
    backxmax = round(backroi(1,3)); 
    backgroundimg = big_img(backymin:backymax,backxmin:backxmax); 
    backbright = mean(mean(backgroundimg)); 
    background_bead = pi*49*backbright; 
    %backmin = background_bead-500; 
    backmax = background_bead+600; 
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    % Create figure and show original feed 
    set(gcf, 'units','normalized','outerposition',[0 0 1 1]); 
    drawnow; 
    subplot(2, 3, 2) 
    dup = imadjust(originalImage); 
    imshow(dup) 
    caption = sprintf('Video feed'); 
    title(caption, 'FontSize', captionFontSize); 
    axis image;  
  
    subplot(2, 3, 1) 
    dup2 = imadjust(big_img); 
    imshow(dup2); 
    caption = sprintf('Full video feed'); 
    title(caption, 'FontSize', captionFontSize); 
    %Show masked video feed 
    maskedImage = originalImage; 
    subplot(2, 3, 4) 
    imshow(backgroundimg) 
    caption = sprintf('Background feed'); 
    title(caption, 'FontSize', captionFontSize); 
  
    %Show circle detection done on masked video feed and calculate 
brightness 
    finaldup = maskedImage; 
    subplot(2, 3, 5) 
    imshow(dup) 
    caption = sprintf('Analysis program'); 
    title(caption, 'FontSize', captionFontSize); 
    [cent,radi,values] = o_detect_outliers(originalImage,finaldup); 
    numbercircles = length(values); 
    values = rot90(values,-1); 
  
    if numbercircles == 0 
        avgbright(ii) = NaN; 
    else 
        %Eliminate beads found to be within threshold value of background 
  
        values(values<backmax) = NaN; 
        backgroundIndex = find(isnan(values)); 
        radi(backgroundIndex) = 1; 
        %Take beads found to be above background and add them to bead 
        %history. If beads are found to be above 3 STD from avg history, 
        %ignore for now 
        bead_buffer = vertcat(bead_buffer(numbercircles:50),values); 
        buffermean = nanmean(bead_buffer); 
        bufferstd = nanstd(bead_buffer); 
        outlierIndex = find(abs(bead_buffer-buffermean) > 3*bufferstd); 
        outlierIndex = outlierIndex - 51 + numbercircles; 
        actualindex = outlierIndex(outlierIndex>0); 
        %values 
        values(actualindex) = NaN; 
        %values 
        radi(actualindex) = 1; 
        avgbright(ii) = nanmean(values); 
        avgbright(ii) = avgbright(ii)-background_bead; 
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        h = viscircles(cent,radi); 
         
        %Take top half of values (experimental...) 
        numNaN = sum(isnan(values)); 
        numbeads = length(values) - numNaN; 
        num2count = ceil(numbeads/2); 
        sortedvalues = sort(values,'descend'); 
        topvalues = sortedvalues(1:num2count); 
        avgtopvalues(ii) = mean(topvalues) - background_bead; 
    end 
  
    elapsedtime = toc; 
    times(ii) = times(ii-1)+elapsedtime; 
    subplot(2,3,6) 
    plot(times(2:ii),avgbright(2:ii)) 
    background4later(ii) = background_bead; 
    ii=ii+1; 
end 
  
%Shift data over one value to get rid of annoying avg_bright = 0 at t = 0 
corrected_avgbright = avgbright; 
corrected_topval = avgtopvalues; 
corrected_topval(1) = avgtopvalues(2); 
corrected_avgbright(1) = avgbright(2); %fix starting value is 0 later... 
background4later(1) = background4later(2); %ditto... 
corrected_times = times./60; 
end 
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Appendix B: Monte-Carlo simulation of scaffold sensor 
 
function [mol_weight,cur] = func_MC_dna4(yy,flexangle,protang) 
%Inputs are yy    ==> number of DNA strands to simulate (usually between 
50000 
%                     to 100000 
%           angle ==> angle in radians by which the DNA can vary from 
%                     perpendicular 
% 
%Outputs are mol_weight ==> a string containing molecular weights 
%            cur        ==> the current at each MW 
  
disp 
'======================================================================== 
' 
disp '                       Anchor Strand Simulation                          
' 
disp 
'======================================================================== 
' 
  
cur = zeros(1,37); 
mol_weight = zeros(1,37); 
%Cycle through molecular weights from 5 to 150 
for uu = 1:30 
    disp 'Current MW: ' 
    mol_weight(uu) = 5*uu 
    disp 'Current current: ' 
    cur(uu) = MC_current_calc(yy,mol_weight(uu),flexangle,protang); 
end 
  
%Also do MW = 200 kDa and 250 kDa 
disp 'Current MW: ' 
mol_weight(31) = 160 
disp 'Current current: ' 
cur(31) = MC_current_calc(yy,mol_weight(31),flexangle,protang); 
disp 'Current MW: ' 
mol_weight(32) = 170 
disp 'Current current: ' 
cur(32) = MC_current_calc(yy,mol_weight(32),flexangle,protang); 
disp 'Current MW: ' 
mol_weight(33) = 180 
disp 'Current current: ' 
cur(33) = MC_current_calc(yy,mol_weight(33),flexangle,protang); 
disp 'Current MW: ' 
mol_weight(34) = 190 
disp 'Current current: ' 
cur(34) = MC_current_calc(yy,mol_weight(34),flexangle,protang); 
disp 'Current MW: ' 
mol_weight(35) = 200 
disp 'Current current: ' 
cur(35) = MC_current_calc(yy,mol_weight(35),flexangle,protang); 
disp 'Current MW: ' 
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mol_weight(36) = 225 
disp 'Current current: ' 
cur(36) = MC_current_calc(yy,mol_weight(36),flexangle,protang); 
disp 'Current MW: ' 
mol_weight(37) = 250 
disp 'Current current: ' 
cur(37) = MC_current_calc(yy,mol_weight(37),flexangle,protang); 
  
%Plot results... 
plot(mol_weight,cur) 
end 
  
  
  
function avg_current = MC_current_calc(aa,MW,angle,protangle) 
  
%Set aside some memory and define constants 
Lp = 534; %Persistance length of dsDNA 
num = 27; %Number of bases 
beadwidth = 3.01; %ANGSSTROMS! DOUBLE CHECK VALUES! 
r = beadwidth/2; 
avgw = .6178; %THIS IS AVERAGE TWIST IN RADIANS 
l = 3.38; %BEAD TO BEAD LENGTH (Angstroms) 
kb = 1; %SUBSTITUTE BOLTZMANS CONST 
T = 300; %TEMPERATURE 
totalenergy = zeros(1,aa); 
finalz = zeros(1,aa); 
protein_location = zeros(1,aa); 
probability_config = zeros(1,aa); 
k_eT = zeros(1,aa); 
prob_eT = zeros(1,aa); 
numAA = MW/.110; 
%Rg = .395*(numAA)^(0.6) + 7.257; 
Rg = 7.78.*MW.^(.37); 
  
parfor ii = 1:aa 
     
    utracker = 0; 
    wtracker = 0; 
  
    %Give the DNA an initial position and angle due to carbon-carbon 
    %bonds linking it to the surface 
    shiftu = (angle)*randn; 
    shiftw = 2*pi*rand; 
    initialw = shiftw; 
    rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
    rotate_w = [cos(initialw),-
sin(initialw),0;sin(initialw),cos(initialw),0;0,0,1]; 
    positions = 
[6*sin(shiftu)*cos(shiftw),6*sin(shiftu)*sin(shiftw),6*cos(shiftu)]; 
     
    %Now calculate the actual positions of the backbone 
    baseposition = [10,0,0]; 
    otherbase = [-10,0,0]; 
  107 
    corrected_base_pos = rotate_w*(rotate_u*baseposition'); 
    corrected_other_base = rotate_w*(rotate_u*otherbase'); 
    actual_base_pos = corrected_base_pos' + positions; 
    actual_other_base = corrected_other_base' + positions; 
    %shift_comp_w = 0; 
    bendenergy = zeros(1,num-1); 
    twistenergy = zeros(1,num-1); 
    Uelectrostatic = zeros(1,num-1); 
    %electrostaticenergy = zeros(1,num); 
  
     
    %Generate positions for each of the base pairs 
    for jj = 2:num 
        %Choose a random bending angle and rotation angle 
        rand_u = (pi/60)*randn; 
        rand_w = 0; 
        base_rand_w = avgw + 0.0125*avgw*randn; 
         
        %Calculate cartesian coordinates of jjth bead in reference frame 
of jj-1 bead 
        rotated_ref_pos = 
[l*sin(rand_u)*cos(rand_w),l*sin(rand_u)*sin(rand_w),l*cos(rand_u)]; 
        base_ref_pos = [10*cos(shiftw),10*sin(shiftw),0]; 
        comp_base_ref_pos = [10*cos(-shiftw+pi),10*sin(-shiftw+pi),0]; 
         
        %Calculate rotation matricies needed to shift n-1 bead frame to 
default frame    
        rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
        rotate_w = [cos(initialw),-
sin(initialw),0;sin(initialw),cos(initialw),0;0,0,1]; 
         
        %Apply rotation matricies to go from bead frame to default frame 
        corrected_ref_pos = rotate_w*(rotate_u*rotated_ref_pos'); 
        corrected_base_pos = rotate_w*(rotate_u*base_ref_pos'); 
        corrected_comp_base = rotate_w*(rotate_u*comp_base_ref_pos'); 
         
        %And then get everything from (0,0,0) frame 
        pos_previous = positions(:,:,jj-1); 
%         comp_pos_previous = actual_base_pos(:,:,jj-1); 
%         otherbase_previous = actual_other_base(:,:,jj-1); 
        actual_pos = corrected_ref_pos' + pos_previous; 
        comp_actual_pos = corrected_base_pos'+actual_pos; 
        comp_base_pos = corrected_comp_base' + actual_pos; 
        
        %Record position, twist, bend for bead jj 
        positions = cat(3,positions,actual_pos); 
        actual_base_pos = cat(3,actual_base_pos,comp_actual_pos); 
        actual_other_base = cat(3,actual_other_base,comp_base_pos); 
         
  
         
        %Keep track of overall shift in reference frame for next bead 
        shiftu = shiftu+rand_u; 
        shiftw = shiftw+base_rand_w; 
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        utracker(jj) = rand_u; 
        wtracker(jj) = rand_w; 
         
        %Calculate energy of bead jj in terms of kT's 
        bendenergy(jj-1) = (Lp/l)*(1-cos(rand_u)); 
        %twistenergy(jj-1) = 0; 
        twistenergy(jj-1) = 0.5*203.49*(base_rand_w-avgw)^2; 
        Uelectrostatic(jj) = 0;%0.001*(38.63)*(2.053)*exp(-
comp_base_pos(3)/7)+(38.63)*(2.053)*exp(-comp_actual_pos(3)/7);  
        %This is the electrostatic energy between each base and the 
surface, normalized by kT, given all of the shit in 
        %your lab notebook from 1/16/18 (page 26). Includes salt screening 
        %for 150mM salt (i.e. 1x PBS) 
    end 
     
    %Add the protein on the end of the DNA chain. Right now we are not 
    %considering bend energy or twist energy here. Note that the protein 
    %position is given in the 'positions' variable and is attached to the 
    %backbone 
     
    rand_uAA = (protangle)*rand; 
    rand_wAA = 0.25*avgw*randn; 
    backbone_pos_previous = actual_base_pos(:,:,num); 
    rotated_ref_pos = 
[(l+Rg)*sin(rand_uAA)*cos(rand_wAA),(l+Rg)*sin(rand_uAA)*sin(rand_wAA),(l+
Rg)*cos(rand_uAA)]; 
    prot_rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
    prot_rotate_w = [cos(shiftw),-
sin(shiftw),0;sin(shiftw),cos(shiftw),0;0,0,1]; 
    prot_corrected_ref_pos = 
prot_rotate_w*(prot_rotate_u*rotated_ref_pos'); 
    actual_pos = prot_corrected_ref_pos' + backbone_pos_previous; 
    positions = cat(3,positions,actual_pos); %Access to the protein 
location is in the 'positions' variable at index num+1 
     
    %Now consider the placement of the methylene blue (which should be 
    %normal to the last AA on the anchor strand and ~7 angtroms away 
     
    uMB = pi/2; 
    wAA = 0; 
    MB_pos_previous = actual_other_base(:,:,num); 
    rotated_ref_pos = 
[7*sin(uMB)*cos(wAA),7*sin(uMB)*sin(wAA),7*cos(uMB)]; 
    rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
    rotate_w = [cos(shiftw),-
sin(shiftw),0;sin(shiftw),cos(shiftw),0;0,0,1]; 
    corrected_ref_pos = rotate_w*(rotate_u*rotated_ref_pos'); 
    actual_pos = corrected_ref_pos' + MB_pos_previous; 
    positions = cat(3,positions,actual_pos); %Access to the MB location is 
in the 'positions' variable at index num+2 
     
     x = positions(:,1,:,:); 
     y = positions(:,2,:,:); 
     z = positions(:,3,:,:); 
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     zz = z(num+1); %This is z-location of protein 
  
      
     %Check to see if the protein is in contact with the monolayer and 
     %calculate energies 
     if zz<(Rg+9.24) %9.24 is approx the length of mercaptohexanol in 
Angstroms 
         totalenergy(ii) = NaN; 
         finalz(ii)= z(num); 
         zMB = z(num+2); 
         protein_location(ii) = zz; 
         probability_config(ii) = 0; 
         k_eT(ii) = NaN; 
     else 
        totalenergy(ii) = sum(bendenergy) + sum(twistenergy); 
        finalz(ii) = z(num); 
        zMB = z(num+2); 
        if zMB<9.25 
            zMB = 9.25; 
        end 
        protein_location(ii) = zz; 
        probability_config(ii) = exp(-totalenergy(ii)); 
        k_eT(ii) = 4400*(exp(-(zMB-9.24)*(1.2))); 
     end 
end 
  
%Go through and normalize the probability function 
totalprob = sum(probability_config); 
normal_prob = probability_config./totalprob; 
  
  
%for each configuration, find the probability of electron transfer 
  
for zzz = 1:aa 
    prob_eT(zzz) = k_eT(zzz)*normal_prob(zzz); 
end 
avg_current = nansum(prob_eT); 
end 
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Appendix C: Monte-Carlo simulation of aptamer-based sensors 
%Function to calculate electron transfer rate of ssDNA 
function [keT_observed,count_yes,MBpos,keT,positions,delE_average_history] 
= MCss_DNA_3(nsteps,lengthDNA) 
count_yes = 0; 
count_no = 0; 
T = 300; %Temp in kelvin 
Lb = .676; %length per base in nanometers of ssDNA 
Lp = 2.223; %persistence length of ssDNA in nm 
MBpos = zeros(nsteps,1); 
keT = zeros(nsteps,1); 
magnitude_bend_shift = 1;  
magnitude_twist_shift = 1;  
delE_average_history = zeros(1,nsteps); 
time = 0; 
electrons_transfered = 0; 
diff_const = (3.096e8)*(lengthDNA)^(-.571); % nm^2/s taken from Lukacs et  
                                            % al J. Bio. Chem. 1999 
(initial value) and Robertson 
                                            % et al. PNAS 2006 (for the 
                                            % length dependence)  
  
%Create initial ssDNA complex standing straight up 
delE_history = []; 
  
  
xpos = zeros(lengthDNA,1); 
ypos = zeros(lengthDNA,1); 
zpos = zeros(lengthDNA,1); 
  
for jj = 1:lengthDNA 
    zpos(jj) = jj*Lb; 
end 
bend = zeros(lengthDNA,1); 
twist = zeros(lengthDNA,1);     
  
%start changing the structure 
positions = [xpos,ypos,zpos]; 
  
for kk = 1:nsteps 
    pos_old = positions(lengthDNA,:); 
    delE_total  = 0; 
    for ll = 1:lengthDNA 
  
        %Choose random bend/twist 
        delta_rand_bend = (randn-.5)*magnitude_bend_shift;  
        delta_rand_twist = 2*pi*rand-pi; %Changed to be FJC model... 
        %delta_rand_twist = (randn-.5)*magnitude_twist_shift;  
        bend_temp = bend; 
        twist_temp = twist;       
        bend_temp(ll) = bend(ll) + delta_rand_bend; 
        twist_temp(ll) = twist(ll) + delta_rand_twist; 
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        temppositions = 
update_position2(lengthDNA,Lb,positions,bend_temp,twist_temp,ll); 
        count_while = 0; 
        %Check if everything is above z = 0 plane, update if not 
        while all(temppositions(:,3)>0)==0 
            count_while = count_while+1; 
            temppositions(:,3); 
            delta_rand_bend = 0.9*delta_rand_bend; 
            delta_rand_twist = 0.9*delta_rand_twist; 
            bend_temp(ll) = bend(ll) + delta_rand_bend; 
            twist_temp(ll) = twist(ll) + delta_rand_twist; 
            temppositions = 
update_position2(lengthDNA,Lb,positions,bend_temp,twist_temp,ll); 
            if count_while > 1000 
                delta_rand_bend 
                delta_rand_twist 
                ll 
                kk 
                positions 
                temppositions 
                'While-loop is stuck' 
                return 
            end 
                 
        end 
  
        'done!'; 
        %Calculate internal bend energy 
        del_E_bend = -(Lp/Lb)*(1-cos(bend(ll))) + (Lp/Lb)*(1-
cos(bend_temp(ll)));  
        del_E_twist = 0;  
        del_E = del_E_bend + del_E_twist; 
  
        %Depending on the energy, update bend/twist 
        if del_E < 0 ||  exp(-del_E) > rand  
  
            deltaU_electro = calc_electrostatics(positions,temppositions,-
.25); 
  
                if deltaU_electro < 0 ||  exp(-deltaU_electro) > rand  
                    positions = temppositions; 
                    twist = twist_temp; 
                    bend = bend_temp; 
                    delE_total = delE_total + deltaU_electro; 
                    'yes'; 
                    count_yes = count_yes + 1; 
                else 
                    'no; electrostatics'; 
                    count_no = count_no +1; 
                end 
  
        else 
            count_no = count_no +1; 
  
            'no'   ;               
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        end 
  
        delE_total = delE_total + del_E;  
%             xpos = positions(:,1); 
%             ypos = positions(:,2); 
        zpos = positions(:,3); 
%             figure  
%             plot3(xpos,ypos,zpos) 
    end 
     
    pos_new = positions(lengthDNA,:); 
    diff_dist = norm(pos_old.^2 - pos_new.^2); 
    timestep = (diff_dist^2)/(6*diff_const); 
     
    delE_history = [delE_history, delE_total];  
    time = time+timestep; 
    zMB = positions(lengthDNA,3); 
    MBpos(kk) = zMB; 
    keT(kk) = 4400*(exp(-(zMB)*(1.2)));  
    prob_eT = keT(kk)*timestep; 
     
    %Determine if electron transfer happens 
    if prob_eT > rand 
        electrons_transfered = electrons_transfered+1 
        time 
        kk 
        'rate (Hz)' 
        electrons_transfered/time 
        if electrons_transfered > 100 
            keT_observed = electrons_transfered/time; 
            return 
        end 
    end 
     
  
end 
%Take z pos of final base and use to calculate keT 
  
keT_observed = electrons_transfered/time; 
delE_average_history = delE_average_history + delE_history; 
delE_average_history = delE_average_history./(lengthDNA);    
%  count_yes 
%  count_no 
    
             
             
 
%Function to calculate electron transfer rate of bound-state aptamer 
function [keT_observed,count_yes,MBpos,keT,positions] = 
MC_aptamer2(nsteps,length_stem,length_tail) 
count_yes = 0; 
count_no = 0; 
T = 300; %Temp in kelvin 
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Lb = .676; %length per base in nanometers of ssDNA 
Lp = 2.223; %persistence length of ssDNA in nm 
MBpos = zeros(nsteps,1); 
keT = zeros(nsteps,1); 
magnitude_bend_shift = 1;  
magnitude_twist_shift = 1;  
delE_average_history = zeros(1,nsteps); 
time = 0; 
electrons_transfered = 0; 
lengthDNA = length_stem+length_tail; 
diff_const = 2*(((3.096e8)*(lengthDNA)^(-.6))^(-1) + (1.2e8)^(-1))^(-1); % 
nm^2/s taken from Lukacs et  
                                            % al J. Bio. Chem. 1999 
(initial value) and Robertson 
                                            % et al. PNAS 2006 (for the 
                                            % length dependence) VALUE IS 
-.571 
  
temp_top_pos = [0,0,(length_tail+4)*Lb]; 
time_old = 0; 
%Create initial ssDNA complex standing straight up 
delE_history = []; 
xpos = zeros(lengthDNA,1); 
ypos = zeros(lengthDNA,1); 
zpos = zeros(lengthDNA,1); 
  
for jj = 1:length_stem 
    zpos(jj) = jj*Lb; 
end 
  
for jj = 1:length_tail 
    ind = length_stem+jj; 
    zpos(ind) = zpos(length_stem) - (jj-1)*Lb; 
    xpos(ind) = 2; 
end 
  
bend = zeros(lengthDNA,1); 
twist = zeros(lengthDNA,1);     
  
%start changing the structure 
positions = [xpos,ypos,zpos]; 
kk = 0; 
  
%This keeps the code from taking forever to run but returns slightly 
%noisier data... 
if lengthDNA < 6 
    max_electrons = 100; 
elseif lengthDNA < 10 
    max_electrons = 75; 
elseif lengthDNA < 14 
    max_electrons = 50; 
else 
    max_electrons = 30; 
end 
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%Main loop 
while electrons_transfered < max_electrons 
    kk = kk+1; 
    pos_old = positions(lengthDNA,:); 
    pos_old_top = temp_top_pos; 
    delE_total  = 0; 
    for ll = 1:lengthDNA 
  
        %Choose random bend/twist 
        delta_rand_bend = (randn-.5)*magnitude_bend_shift;  
        delta_rand_twist = 2*pi*(rand-.5);  
        %delta_rand_twist = (randn-.5)*magnitude_twist_shift;  
  
        bend_temp = bend; 
        twist_temp = twist;       
        bend_temp(ll) = bend(ll) + delta_rand_bend; 
        twist_temp(ll) = twist(ll) + delta_rand_twist; 
  
        [temppositions,temp_top_pos] = 
update_position_aptamer(length_stem,length_tail,Lb,positions,bend_temp,twi
st_temp,ll); 
        count_while = 0; 
        %Check if everything is above z = 0 plane, update if not 
        while all(temppositions(:,3)>0)==0 
            count_while = count_while+1; 
            temppositions(:,3); 
            delta_rand_bend = 0.9*delta_rand_bend; 
            delta_rand_twist = 0.9*delta_rand_twist; 
            bend_temp(ll) = bend(ll) + delta_rand_bend; 
            twist_temp(ll) = twist(ll) + delta_rand_twist; 
            [temppositions,temp_top_pos] = 
update_position_aptamer(length_stem,length_tail,Lb,positions,bend_temp,twi
st_temp,ll); 
        end 
  
        'done!'; 
        %Calculate internal bend energy 
        del_E_bend = -(Lp/Lb)*(1-cos(bend(ll))) + (Lp/Lb)*(1-
cos(bend_temp(ll)));  
%         del_E_twist = 0;  
        del_E = del_E_bend; 
  
        %Depending on the energy, update bend/twist 
        if del_E < 0 ||  exp(-del_E) > rand  
  
            deltaU_electro = calc_electrostatics(positions,temppositions,-
.35); 
  
                if deltaU_electro < 0 ||  exp(-deltaU_electro) > rand  
                    positions = temppositions; 
                    twist = twist_temp; 
                    bend = bend_temp; 
                    delE_total = delE_total + deltaU_electro; 
                    'yes'; 
                    count_yes = count_yes + 1; 
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                else 
                    'no; electrostatics'; 
                    count_no = count_no +1; 
                end 
  
        else 
            count_no = count_no +1; 
  
            'no'   ;               
  
        end 
  
        delE_total = delE_total + del_E;  
%             xpos = positions(:,1); 
%             ypos = positions(:,2); 
        zpos = positions(:,3); 
%             figure  
%             plot3(xpos,ypos,zpos) 
    end 
     
    pos_new = positions(lengthDNA,:); 
    top_pos_new = temp_top_pos; 
     
    diff_dist_top = norm(top_pos_new.^2 - pos_old_top.^2); 
    diff_dist = norm(pos_old.^2 - pos_new.^2); 
     
    max_diff_dist = max([diff_dist, diff_dist_top]); 
    timestep = (max_diff_dist^2)/(6*diff_const); 
     
    delE_history = [delE_history, delE_total];  
    time = time+timestep; 
    zMB = positions(lengthDNA,3); 
    MBpos(kk) = zMB; 
    keT(kk) = 4400*(exp(-(zMB)*(1.2)));  
    prob_eT = keT(kk)*timestep; 
     
    %Determine if electron transfer happens 
    if prob_eT > rand 
        time_new = time; 
        time_diff = time_new-time_old; 
        if time_diff>.0005 
            electrons_transfered = electrons_transfered+1 
            time 
            time_diff 
            kk 
            'rate (Hz)' 
            electrons_transfered/time 
            time_old = time_new; 
        end 
        if electrons_transfered > 100 
            keT_observed = electrons_transfered/time; 
            return 
        end 
    end 
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end 
%Take z pos of final base and use to calculate keT 
  
keT_observed = electrons_transfered/time; 
%delE_average_history = delE_average_history + delE_history; 
%delE_average_history = delE_average_history./(lengthDNA);    
%  count_yes 
%  count_no 
    
             
             
 
%function to calculate electrostatic effects 
function deltaU = 
calc_electrostatics(positions_before,positions_after,voltage) 
%Testing GitHub updates with this comment. Please ignore... 
q_star = 38.92; % q/kT in Volts^-1 at 25 Celcius 
z_before = positions_before(:,3); 
z_after = positions_after(:,3); 
num_bases = length(z_before); 
u_before = zeros(1,num_bases); 
u_after = zeros(1,num_bases); 
  
%Here we model the voltage as an exponential decay with a debye length of 
%.785 nm, equivalent to that of a 150 mM electrolyte solution (i.e. 1xPBS 
solution) 
for ii = 1:num_bases 
    u_before(ii) = -voltage*q_star*exp(-z_before(ii)/.785); 
    u_after(ii) = -voltage*q_star*exp(-z_after(ii)/.785); 
end 
  
deltaU = sum(u_after)-sum(u_before); 
% deltaU = 0.1*deltaU; 
 
 
%Function handling position updates for bound state aptamer 
function [positions,temp_position] = 
update_position_aptamer(length_stem,length_tail,Lb,positions,bend_temp,twi
st_temp,ll) 
lengthDNA = length_stem+length_tail; 
  
if ll > length_stem 
    ll = length_stem; 
end 
  
if ll <= length_stem 
    %Calculate positions of the stem bases first 
    for ii = ll:length_stem 
  
        if ii == 1 
            position_last = [0,0,0]; 
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        else 
            position_last = positions(ii-1,:); 
        end 
  
        current_bend = bend_temp(ii); 
        current_twist = twist_temp(ii); 
  
        shiftu = sum(bend_temp(1:ii)) - current_bend; 
        shiftw = sum(twist_temp(1:ii)) - current_twist; 
  
        rotated_ref_pos = 
[Lb*sin(current_bend)*cos(current_twist),Lb*sin(current_bend)*sin(current_
twist),Lb*cos(current_bend)]; 
        rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
        rotate_w = [cos(shiftw),-
sin(shiftw),0;sin(shiftw),cos(shiftw),0;0,0,1]; 
        corrected_base_pos = rotate_w*(rotate_u*rotated_ref_pos'); 
  
        positions(ii,:) = position_last + corrected_base_pos'; 
        position_last = positions(ii,:); 
    end 
     
    %Calculate the position of the last complementary base 
    shiftufinal = sum(bend_temp(1:length_stem)); 
    shiftwfinal = sum(twist_temp(1:length_stem)); 
    comp_transformation = [2*cos(shiftufinal), 2*sin(shiftwfinal), 0]; 
    rotate_u = [cos(shiftufinal),0,sin(shiftufinal);0,1,0;-
sin(shiftufinal),0,cos(shiftufinal)]; 
    rotate_w = [cos(shiftwfinal),-
sin(shiftwfinal),0;sin(shiftwfinal),cos(shiftwfinal),0;0,0,1]; 
    corrected_comp = rotate_w*(rotate_u*comp_transformation'); 
    positions(length_stem+1,:) = positions(length_stem,:) + 
corrected_comp'; 
    positions_last = positions(length_stem+1,:); 
     
    %calculate the position of the top-most complementary base (assuming 5 
    %total complementary bases) 
    rotated_ref_pos = 
[12*Lb*sin(current_bend)*cos(current_twist),12*Lb*sin(current_bend)*sin(cu
rrent_twist),12*Lb*cos(current_bend)]; 
    rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
    rotate_w = [cos(shiftw),-
sin(shiftw),0;sin(shiftw),cos(shiftw),0;0,0,1]; 
    corrected_base_pos = rotate_w*(rotate_u*rotated_ref_pos'); 
    temp_position = positions(length_stem,:) + corrected_base_pos'; 
     
    %Calculate positions of the tail bases 
    for mm = 2:length_tail 
        index = length_stem + mm; 
        current_bend = bend_temp(index); 
        current_twist = twist_temp(index); 
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        shiftu = shiftufinal - sum(bend_temp(length_stem+1:index)) + 
current_bend; 
        shiftw = shiftwfinal - sum(twist_temp(length_stem+1:index)) + 
current_twist; 
         
        rotated_ref_pos = 
[Lb*sin(current_bend)*cos(current_twist),Lb*sin(current_bend)*sin(current_
twist),Lb*cos(current_bend)]; 
        rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
        rotate_w = [cos(shiftw),-
sin(shiftw),0;sin(shiftw),cos(shiftw),0;0,0,1]; 
        corrected_base_pos = rotate_w*(rotate_u*rotated_ref_pos'); 
         
        positions(index,:) = positions_last - corrected_base_pos'; 
        positions_last = positions(index,:); 
    end 
%if ll starts after the complementary base, there is no need to calculate 
stem base positions     
elseif ll == length_stem+1 
    shiftufinal = sum(bend_temp(1:length_stem)); 
    shiftwfinal = sum(twist_temp(1:length_stem)); 
    comp_transformation = [2*cos(shiftufinal), 2*sin(shiftwfinal), 0]; 
    rotate_u = [cos(shiftufinal),0,sin(shiftufinal);0,1,0;-
sin(shiftufinal),0,cos(shiftufinal)]; 
    rotate_w = [cos(shiftwfinal),-
sin(shiftwfinal),0;sin(shiftwfinal),cos(shiftwfinal),0;0,0,1]; 
    corrected_comp = rotate_w*(rotate_u*comp_transformation'); 
    positions(length_stem+1,:) = positions(length_stem,:) + 
corrected_comp'; 
    positions_last = positions(length_stem+1,:); 
     
    %Calculate positions of the tail bases 
    for mm = 2:length_tail 
        index = length_stem + mm; 
        current_bend = bend_temp(index); 
        current_twist = twist_temp(index); 
         
        shiftu = shiftufinal - sum(bend_temp(length_stem+1:index)) + 
current_bend; 
        shiftw = shiftwfinal - sum(twist_temp(length_stem+1:index)) + 
current_twist; 
         
        rotated_ref_pos = 
[Lb*sin(current_bend)*cos(current_twist),Lb*sin(current_bend)*sin(current_
twist),Lb*cos(current_bend)]; 
        rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
        rotate_w = [cos(shiftw),-
sin(shiftw),0;sin(shiftw),cos(shiftw),0;0,0,1]; 
        corrected_base_pos = rotate_w*(rotate_u*rotated_ref_pos'); 
         
        positions(index,:) = positions_last - corrected_base_pos'; 
        positions_last = positions(index,:); 
    end 
else 
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    shiftufinal = sum(bend_temp(1:length_stem)); 
    shiftwfinal = sum(twist_temp(1:length_stem)); 
        %Calculate positions of the tail bases 
    for nn = ll:length_tail 
         
        index = length_stem + nn; 
        positions_last = positions(index-1,:); 
        current_bend = bend_temp(index); 
        current_twist = twist_temp(index); 
         
        shiftu = shiftufinal - sum(bend_temp(length_stem+1:index)) + 
current_bend; 
        shiftw = shiftwfinal - sum(twist_temp(length_stem+1:index)) + 
current_twist; 
         
        rotated_ref_pos = 
[Lb*sin(current_bend)*cos(current_twist),Lb*sin(current_bend)*sin(current_
twist),Lb*cos(current_bend)]; 
        rotate_u = [cos(shiftu),0,sin(shiftu);0,1,0;-
sin(shiftu),0,cos(shiftu)]; 
        rotate_w = [cos(shiftw),-
sin(shiftw),0;sin(shiftw),cos(shiftw),0;0,0,1]; 
        corrected_base_pos = rotate_w*(rotate_u*rotated_ref_pos'); 
         
        positions(index,:) = positions_last - corrected_base_pos'; 
    end 
end 
         
 
